ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000266.1|Rubromycin_1 # 1 # 96 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.677	BGC0000266.1|Rubromycin_1 	1	96	+	Loose	400	21.9422	ErmS	44.44	3001304	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GAATTCATCGCCCACGTCCGGTTCTCCGGCAGCGGCTATGTGTCGCTCCCCCTTCCCTTCGACGGCGGCGTGGAAATGGCCGTCCGCGCCGCCTGA	EFIAHVRFSGSGYVSLPLPFDGGVEMAVRAA	MARAPRSPHPARSRETSRAHPPYGTRADRAPGRGRDRDRSPDSPGNTSSRDGGRSPDRARRELSQNFLARRAVAERVARLVRPAPGGLLLEVGAGRGVLTEALAPYCGRLVAHEIDPRLLPALRDRFGGPHHAHVRISGGDFLAAPVPREPFALAGNIPYSRTAGIVDWALRARTLTSATFVTQLEYARKRTGDYGRWSLLTVRTWPRHEWRLLGRVSRREFRPVPRVDSGILRIERRERPLLPSAALGDYHRMVELGFSGVGGSLYASLRRAHRAGPLDAAFRAARLDRSVVVAYVTPEQWLTVFRTLRPVRSRPAGR	9.72	gnl|BL_ORD_ID|671|hsp_num:0	727			396	450	lincomycin; tylosin; pristinamycin IC; carbomycin; niddamycin
BGC0000266.1|Rubromycin_2 # 182 # 508 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.709	BGC0000266.1|Rubromycin_2 	182	508	+	Loose	900	22.7126	lmrB	23.33	3002813	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGTCCCCTCGTCCGTTCGACCCGGAGTTCCTGCCCGAGGGACACCCCGACAAGAACCCCGTCCCACCCCGCGGCACCGCCTCGCGCGCCCTGTGGCGAGGGCTGGTTCGCTACCTCCTGCTGCCGGCGTACCGCGCGCTGGTGGCCCTCGGATCGGTGCACGTGGCAGCGCTCTGGCATCCGGAGTTCGGGCCCGCGGTCAGCCGGCCGCCGCAGGAGCCGCCGAGCTACAGGACGTTTCGAGCGGGTCTTGAGAGCGGGCCGGAAGCCTGGCCGGGACATCCCCACCCCCCAGTTCCCAGAGAGAATCGAGGAGATCTGTCATGA	MSPRPFDPEFLPEGHPDKNPVPPRGTASRALWRGLVRYLLLPAYRALVALGSVHVAALWHPEFGPAVSRPPQEPPSYRTFRAGLESGPEAWPGHPHPPVPRENRGDLS	METTAKASQQYKVMPIMISLLLAGFIGMFSETALNIALTDLMKELNITAATVQWLTTGYLLVLGILVPVSGLLLQWFTTRQLFTVSLIFSILGTFIAALAPSFSFLLAARIVQALGTGLLLPLMFNTILVIFPPHKRGAAMGTIGLVIMFAPAIGPTFSGLVLEHLNWHWIFWISLPFLVLALVFGIAYMQNVSETTKPKIDVLSIILSTIGFGGIVFGFSNAGEGSGGWSSPTVIVSLIVGVVGLILFSIRQLTMKQPMMNLRAFKYPMFILGVIMVFICMMVILSSMLLLPMYLQGGLVLTAFASGLVLLPGGILNGFMSPVTGRLFDKYGPKWLVIPGFVIVTVVLWFFSNVTTTSTAVLIIILHTCLMIGISMIMMPAQTNGLNQLPREFYPDGTAIMNTLQQMAGAIGTAVAVSIMAAGQHDYMSTVKNPADPAVIPQALTAGVQHAFVFAMIVAIIGLIGAFFMKRVKVDH	22.64	gnl|BL_ORD_ID|540|hsp_num:0	592			387	477	
BGC0000266.1|Rubromycin_3 # 505 # 873 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.694	BGC0000266.1|Rubromycin_3 	505	873	+	Loose	175	28.8758	FosG	44.83	3007368	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	ATGAGCGACGCGCGGCTGGTCGGCACCTGGACCACGCAGCTGGACGACGACGGCAAGGCGGTCCCCGGACTCGTCTGCTTCTCGGCGGACGGCACGGTCGTCTCCACCCAGCTCAACACGAAGAACATCGGCCTGGGCACCTGGCGCTCCACGGGCCCGCACAGCTTCGAGTACGGCTTCCACATCCTGGCGGCCGACCCCGAGGGCAACCACGTGGGGGAGGCACATGTCCGGGTGTCGGGCGAGTTCGTCTCGGACACGGAGTGGCAGGGCAACGGCGGTGCCGAGTTCTTCGACCCGCAGGGCACCAAGCTGCGCGGGCACGCGGGGTCCAAGGTGACCGCCGGCAAGTTCGGCATCGACGACTGA	MSDARLVGTWTTQLDDDGKAVPGLVCFSADGTVVSTQLNTKNIGLGTWRSTGPHSFEYGFHILAADPEGNHVGEAHVRVSGEFVSDTEWQGNGGAEFFDPQGTKLRGHAGSKVTAGKFGIDD	MLRGLNHITIAVSDLGRSLAFYTDIVGMLAHVRWDNGAYLSLGGVWFCLSCDKVMPSKDYSHIALDISEDDFASFLEKLRRADVTEWKQNSSEGYSVYFLDPDGNKLEAHSGSLQSRLSSLKDKPYPGLVWL	92.42	gnl|BL_ORD_ID|4903|hsp_num:0	5896			252	339	fosfomycin
BGC0000266.1|Rubromycin_4 # 873 # 2321 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.741	BGC0000266.1|Rubromycin_4 	873	2321	+	Loose	400	25.409	vanR gene in vanC cluster	42.86	3002922	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGCGGGCGGCGGCGCTGCGGGACCGGCTCGACGGGGACCTGGTTCTGCCGGACGAGACGGGCTTCGCTCTGGCCCGGCAGCTGCAGAACACCGAGTACGACACGATCGAGCCGTCGGCCGTCGCGTACTGCGCCTCCGAGCGGGATGTCGCGCTGTGCGTGCGGCACGCCCGGGAGCAGGGGGTGCGGCTGCACGTCCGGGGCGGCGGACACAGCTTCAACGGCTGGTCGACCGGTGAGGGGCTGGTCGTCGACCTGTCCCGGATGAACCACGCCGTCGCCGAGGGGCCCGTGGTGCGGCTGGGGGCGGGCGTCCAGTCCCTGGACGCGCTGGACGCCCTGCGGTCCCAGGGGCGGCAGATCGTCACCGGGACGTTTCCCACGGTCGCCGCGGGCGGATTTCTGACCGGCGGCGGGATCGGCTGGCAGACGCGCAGGTTCGGGCTGGGCAGCGACCGGGTCGCGGCCGCGCGCGTCGTGCTCGCGGACGGCAGGGCCGTCCGCTGCTCGCCCACCGAGGAACCCGATCTGTACTGGGCCTCGCGCGGCGGGGGCGGCGGCACCTTCGGGGTGGTCACGGAGTTCGAGGTGCGGTCGATCGACGCGCCCGCCATGACCGGCTTCGAGACGCTGTGGGCGTACGACGACGCTGTGGAGGTGCTGACGGCCTGGCAGGAGTGGGCCGTGGACGGCCCCGACGAGCTCGGCACCTCTCTGGTCGTGCTGCCGGGCATGTTCGGGCCCGGCGGGCGCCCCGTGGTCCGGGTCTGGGGGGCGCACCTGGGTCCGGACGAGGCCCTGCACGAGGGTCTGGACGAACTGGCGGAGCGGGCCGGGTGCAAGCCGCTGAGCAGGACCGTCGCCGCGCGGGGCGGGTATGCCGAGGTGATGCACGAGGCGCTGTGCGGCTCGAAGTCGGTGTCCCAGTGCCGTCGTACGGGAACCGGGCCCGAGGCCGAGGGGCACCGCCACCCGTACACCCGGCAGAGCTACCGGCTCACCGGCCGGTCCGCGACCCGGGCGGAATCGGCGGCACTGCTCGATGCCTGGGATCCCGCACTCGACGCGGTGGGCCAGGAGCGCTATCTGCTGTGCATCGCGCTGGGCGGAGCGGCGAACCGGGTGCCGGTCAGCGCCACCGCCTACGCGCACCGGGACGCCCGGTTCCTGATCGGCTATCAGTTCGCCTGCCGTGAGGCGGAGGCGGACCCGGCGGCGCCGGCGCGGCTGACCGCGCTGGCGGACCGTGCCGCCGAGGCACTCACGCCGCTCGCTTGCGGCTCGTACATCAACTTCCCCAGCTCGCGGGTGGGCGGGGACTGGGAGACGGAGTACTTCGGCGCGAACCGGTTCCGGCTGCGCGCCGTGAAGCGGGCCTACGACCCCGAGGACTTCTTCCGGCACGCGCAGAGCATCGGCCGTGCCCCGACGACCGAGGTGGAGTCATGA	MRAAALRDRLDGDLVLPDETGFALARQLQNTEYDTIEPSAVAYCASERDVALCVRHAREQGVRLHVRGGGHSFNGWSTGEGLVVDLSRMNHAVAEGPVVRLGAGVQSLDALDALRSQGRQIVTGTFPTVAAGGFLTGGGIGWQTRRFGLGSDRVAAARVVLADGRAVRCSPTEEPDLYWASRGGGGGTFGVVTEFEVRSIDAPAMTGFETLWAYDDAVEVLTAWQEWAVDGPDELGTSLVVLPGMFGPGGRPVVRVWGAHLGPDEALHEGLDELAERAGCKPLSRTVAARGGYAEVMHEALCGSKSVSQCRRTGTGPEAEGHRHPYTRQSYRLTGRSATRAESAALLDAWDPALDAVGQERYLLCIALGGAANRVPVSATAYAHRDARFLIGYQFACREAEADPAAPARLTALADRAAEALTPLACGSYINFPSSRVGGDWETEYFGANRFRLRAVKRAYDPEDFFRHAQSIGRAPTTEVES	MSEKIVVVDDEKEIADLVTTFLQNEGFSVQPFYDGTSAIAYIEKEAIDLAVLDVMLPDIDGFQLLQQIRKTHFFPVLMLTAKGEDLDKITGLSLGADDYVTKPFNPLEVVARVKTQLRRYQRYNHSTASPTVEEYEKDGLILKINSHQCILYGKEVFLTPIEFKILLYLFEHQGSVVSSETLFEAVWKEKYLDNNNTVMAHIARLREKLHEEPRKPKLIKTVWGVGYIIEK	208.66	gnl|BL_ORD_ID|1500|hsp_num:0	1547			156	219	vancomycin
BGC0000266.1|Rubromycin_5 # 2318 # 3091 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.733	BGC0000266.1|Rubromycin_5 	2318	3091	+	Loose	450	45.0542	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	24.62	3004045	protein variant model	G93V	I47T:1574, I194T:1574	disinfecting agents and antiseptics; isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant fabI	ATGAGGACGGATCTGCGGAACAAGGTCGTACTGGTCACCGGCGCCTCCTCGGGCATCGGCCGGGCGACGGCCGTGGCGTACGGGGAGGAGGGGGCCAAGGTCGCGATCACGTACCACAGCAATGAGGACGGGGCCCGGGAGACGGCCCGGCTGGTGACCGAGGCGGGCGGGACTGCGCTGGTGGTGCGCTACGACCTCGCGGACGAGCGGTGCATACGGGACGCCGTGGGGCGGGTCGCCGAGGAGTGGGGCGGCATCGACGTGTTGGTGGCCAACGCGGTGGTCTGGAGCGAGGCGATCCCGCGGCCCGGGCAGCCGGTGCCGCGCTTCGAGGACGTGCCGGCCAAGCAGTGGCAGGAGGTGCTGCGTACGTCCGTCGACGCCGTGTTCCACACGCTGCAGGCGGTCCTGCCGTGGATGCGCGGACGGCCGTGGGGCCGGATCGTGCTGCTCGGCGCGGGCCTGGCGGACACCGGCAAGGCCGGGGCGGGGGCCTACGGCGCGGGCAAGTCCGCGCTCTTCGGGCTGATGCGCAGCCTGGCCTGGGAGCTGGGGCCCGACGGGATCCTGGTCAACATGGTCGTGCCGGGCCAGACCAGCACCGAGACCGTGCGGGCGCACGTGCCCCCGGGCTTTTTGGAGGAGAAGGGCAAGACCTTGCCGTCGGGCCGGATGTCCGCGCCCGAGGACGTGGCCCGGGCCATCACCTTCCTGGGCTCGGCCGCCAACGGCAACACCAACGGCGAGACGCTCCGCGTGACGGGCGGCGCCTGA	MRTDLRNKVVLVTGASSGIGRATAVAYGEEGAKVAITYHSNEDGARETARLVTEAGGTALVVRYDLADERCIRDAVGRVAEEWGGIDVLVANAVVWSEAIPRPGQPVPRFEDVPAKQWQEVLRTSVDAVFHTLQAVLPWMRGRPWGRIVLLGAGLADTGKAGAGAYGAGKSALFGLMRSLAWELGPDGILVNMVVPGQTSTETVRAHVPPGFLEEKGKTLPSGRMSAPEDVARAITFLGSAANGNTNGETLRVTGGA	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	98.09	gnl|BL_ORD_ID|4712|hsp_num:0	2666			9	750	triclosan
BGC0000266.1|Rubromycin_6 # 3237 # 4232 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.734	BGC0000266.1|Rubromycin_6 	3237	4232	+	Loose	275	30.4166	AAC(6')-Iw	31.82	3002567	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGTTTCGAGAGGCCCGGGCCACCGTGTGGGGCATGGAGATTCGTAGCCTCGACGGCGATGAGCCGGCGACCATTGCCGCGTTGCTTCCCGGATTCCGGGACACCATGAGCCTGGAACTGCCCGGTGATCCACCGGTGACGGAGGCCCTGCTGGCGCGGCTGTTCCAGCGGCGGCACGGGACGGAACGGATCGTGCTGGCCGCGTACGACGGCGGCACCCCGGCCGGTGTGCTGAAGCTGGGGCTCGATCTGGGAGATCCGAGCGGGCCGGGACACGGTTCGCTGTGGGTTTTCCCGGGGTTCCGGCGACGCGGTGCCGGGCGGGCGCTGGTGGCTGCGGGGCTGGTGGCGCTGCGGGAGCGCGGGCGGGAGCTGCTGCTGGCCGACGCTCCCCGGGCGGCGGGCGGCGAGCGGTTCGCGGCGGAGCTCGGAGCCGACCTCATCGGCGAGAGCGTGCGCCATCGGCTCCGCCCGGCCGGGCCCGCTCGCGCGGCGCTGGAGGCGGCCGCAACCCGGCCGGTGCCCGGTTACCGGCTGGTGGCGTGGCAGGGGCCCTGCCCCGACGACCTGGTGGAGTCCTACGCCCGGGCCTGGAGCGCCCTGGAGGAGCGGGTCAACGGCCAGGCCAGGATCCGGCGTCCCTCCGCCGACGACGTACGGGCGCGGGAGGCCGAGGCGGAGCGGGCCGGGCATGTGCCCCACGTGGTGGCGGCACTGCCCGAGCACGGTACGTCGATCGTCGCGTACGCCACCTTGTTCGTGCGCAACAGCCCGATGGCGGACGTCGGCGAGACGCTGGTGCTGCCCAAGCACCGGCGGCGTGGTCTCGCCACCTGGCTGAAGGGCGAACTGCTGCTCGGGGCCGCCCGGGAGAACAACCGGCTCGCGCTGATCCAGGTCTTCAACGACACCGCCGACACCGCTGTGGTCGCGCTCAACCGGAAGCTCGGCTTCGAGGCCGACTCGTACTGGTCGACGTACGCGCTCAAGGCCTGA	MFREARATVWGMEIRSLDGDEPATIAALLPGFRDTMSLELPGDPPVTEALLARLFQRRHGTERIVLAAYDGGTPAGVLKLGLDLGDPSGPGHGSLWVFPGFRRRGAGRALVAAGLVALRERGRELLLADAPRAAGGERFAAELGADLIGESVRHRLRPAGPARAALEAAATRPVPGYRLVAWQGPCPDDLVESYARAWSALEERVNGQARIRRPSADDVRAREAEAERAGHVPHVVAALPEHGTSIVAYATLFVRNSPMADVGETLVLPKHRRRGLATWLKGELLLGAARENNRLALIQVFNDTADTAVVALNRKLGFEADSYWSTYALKA	MKIMPISEALLADWLQLRILLWPDHEDAHLLEMRQLLTRTDSLQLLAYSETQQPIAMLEASIRHEYVNGTQTSPVAFLEGIYVLPEHRRSGIATQLVQQVEQWAKQYACTEFASDAAIDNTISHAMHQALGFHETERVVYFKKNIS	226.71	gnl|BL_ORD_ID|1167|hsp_num:0	1271			210	396	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0000266.1|Rubromycin_7 # 4337 # 5176 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.706	BGC0000266.1|Rubromycin_7 	4337	5176	+	Loose	500	26.9498	BJP-1	43.33	3000856	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	BJP beta-lactamase	ATGACCACCGTGATCCCCGCCAGGCAGCGCACGCGCAACGCCGAGCTGATCCGCGAGCTGTACGGGACGCTCTATCGTGAGCGCCGCTTCGAGGAGGCGGGTCGCTTCTTCCATGCCGACTGCGTCGAGCACGACCCGGGCGACTGGCGGACATCGGACCGTACGTTCCCGGCGCTGCGCGCCGACATCGACCACCTGGTGGCCGGCAACGACCGGGTGATGCTCTTCGCGACCTGGACCGGACGCTCCCGCTCGGGTACCGAACTCCGGTTGCATACCGCTGAGTTGTACCGCCTGCGGGACGGTAGGGTCGCCGAGCACTGGAGCGTGGTGGACCGCGACGTGCTCNTCGGGCACGGTGTGGACGGCGGACCGGACCGGAGCGGTCAGCCGGCTGCCCCGGGTCTGCACGGCCCGCACAGCGACACCGAGCGGGCCAACGCGGAGCTGGTGCTCGGCGCGTACCGCGACGTCTTCAGCGAGCACCGGCTGGAGCTGGCCGAGCGCTACTACCACCAGGACTACCGGCACCACAACATGCGTACGGACGCGGTGCCGGACGGGCTCGACGCGTTCAAGGCGTTCTTCGCCGACAACATCGCCGCCTTCCCCGACCTGGTCACCACCGTGGACCACATCGTCGCCGCCGACGACCGGGTGATGGTCTTCGTCACCTGGACCGGCACGCTCACCGGCGCGTGGAGCGGAGGCGGGCCCTCCGGGCTGCCTCTGGAGATGCGCACCTGCGACCAGTTCCGGATCGAACGCGGGAAGGTCGCCGAGCACTGGGAGGTCGTGGACTACCTGGCCCTGGGGCGGGCCGGGCTGCCGACCCCGTGA	MTTVIPARQRTRNAELIRELYGTLYRERRFEEAGRFFHADCVEHDPGDWRTSDRTFPALRADIDHLVAGNDRVMLFATWTGRSRSGTELRLHTAELYRLRDGRVAEHWSVVDRDVLXGHGVDGGPDRSGQPAAPGLHGPHSDTERANAELVLGAYRDVFSEHRLELAERYYHQDYRHHNMRTDAVPDGLDAFKAFFADNIAAFPDLVTTVDHIVAADDRVMVFVTWTGTLTGAWSGGGPSGLPLEMRTCDQFRIERGKVAEHWEVVDYLALGRAGLPTP	MRRLTAALCALTLLSTGAQAQTIKDFLAVAMKKWTAPFEPFQLIDNIYYVGTDGIAVYVIKTSQGLILMDTAMPQSTGMIKDNIAKLGFKVADIKLILNTHAHLDHTGGFAEIKKETGAQLVAGERDKPLLEGGYYPGDEKNEDLAFPAVKVDRAVKEGDRVTLGDTTLTAHATPGHSPGCTSWEMTVKDGKEDREVLFFCSGTVALNRLVGQPTYAGIVDDYRATFAKAKAMKIDVLLGPHPEVYGMQAKRAEMKDGAPNPFIKPGELVTYATSLSEDFDKQLAKQTAALEKK	94.90	gnl|BL_ORD_ID|1936|hsp_num:0	1942			408	492	
BGC0000266.1|Rubromycin_8 # 5227 # 6894 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGGA;rbs_spacer=7bp;gc_cont=0.740	BGC0000266.1|Rubromycin_8 	5227	6894	+	Loose	550	149.058	Nocardia farcinica rox	32.12	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGACCTCCGCTTCCGAACCTTCCGGCCCTTCCGGCAGCGCACCCGTACTGATCGTCGGCGGCAGCCTCGTCGGCCTGTCCACCGCCGTGTTCCTCGCCCGGCACGGGGTCCGCTGCACTCTGGTGGAGCGCCATCCGGGCACGTCCGTCCATCCGAGGGCCGTCGGGTACTACCCCCGGACCGGCGAACTGCTGCGGCAGGCCGGGGTCGAGGACGCCGCCGTGCGGGAGGCGTCCGGGTTCGCCACGCATCGCACCCGTGCCGGGGTGACCTCGCTGGCCGGCGAGGTGCTGTTCAGCAAGGAGGAGCTGGAGGGCGATGACGATCTGGGCGACCTCACGCCGTCCCGGCTGCTTCTGCTGCCGCAGGACCGGCTGGAGCCGCTGCTGCGGGACCGTGCGGTGGAGCTCGGGGCCGACCTCCGGTTCGGCACGGAACTGGTGTCCTTCGCGGAGGACCCGGAGGGGGTCACCGCCGTCCTCGACGACGGCACCGGCGGCACCCGTACCTTCCGCAGCTCCTACCTGGTGGCCTGCGACGGGCCGCGCAGCACCGTCCGGGAGGCGCTGAAGGTGCCCCGGCAGGGGCGCGGGGTGCTGTCCCGCCATGTGAGCATCGCGTTCGGCGCGGATCTGCGCCCGGTGCTGGGGGACCGCCGCTACAGCGTGGTCCATGTGAAGAACCCCCAGGTCACGGGCATTCTCGTGCATGACGACACCTTGACCGGGGGCACGCTCATCGTCGGGTACCGGCCCGAGGACGGCGAGAGCCTGGAGGACTTCACCGACGACCGCTGCGCCGAGCTGGTGGGGGCCGCGGTGGGAGCGCCGGGGGTCGAGGTGACGATCCGCTCGCGCTTCCCCTGGGACATGGCGGAGCAGGTGGCCGAGAGCTTCGTGCACGGCAGGGTGCTGCTCGCCGGGGACGCGGCTCACGTGGTCCCGCCCACGGGGGGCTACGGCGCCAACACCGGTATCGCCGACGCCCACAACCTCGCCTGGAAGCTCGCCCTGGTGGCCGCGGGCGTCGCAGGGCCCGGCCTCGTGGAGACGTACGACGCCGAGCGGCGGCCCGTGGCGGTCTACACGGCCGAGCAGGGATCCCTCCAGCTCGCACTGCGTTCCGGCACCGCCACCCCGGAGCAGCAGGCCGCCGTCGCGGACGCGGTGACGGTGACGTCGGGGCAGGCGTACCGCTCCACGGCGGTGGTGGGGGAGCCGGACGGCGCGGATCTCCCGGTCGCCTCCGATCCGCGGGAACTGCGCGGGGCGCCGGGCACCCGGGCGCCGTATGTGGAGCTGCTGCGGGGCGGTGAAACGGTGTCCACGCTCGACCTCTTCGGGCGGGACTTCGTCCTGCTGACCGGAGAGCACGGCCGTGAGTGGATCTCGGCGGCCGTCTCCGCCTCCGCCGGACTGGGCCTGAAGATCACCGCCCGCCGGGTGGTGCCGGGTACGGACGCCGGGGCGGGCACCCTGGCCGACCCGGACGGCGACTGGTCCGAGCGCTACGGCGGTCTGCGCCCGGAAGGGGCTGTCCTGGTCAGGCCGGACGGTGTCGTCGCGTGGCGGTCGCCGGGCGCCGACCCGGGAGGCGAGGAGAGCGCGGTGCTGGCAGCGGTGCTGCGGAGTGTCCTCGCGCGAGAGTCCCGCACGGGCGGGAAGTAG	MTSASEPSGPSGSAPVLIVGGSLVGLSTAVFLARHGVRCTLVERHPGTSVHPRAVGYYPRTGELLRQAGVEDAAVREASGFATHRTRAGVTSLAGEVLFSKEELEGDDDLGDLTPSRLLLLPQDRLEPLLRDRAVELGADLRFGTELVSFAEDPEGVTAVLDDGTGGTRTFRSSYLVACDGPRSTVREALKVPRQGRGVLSRHVSIAFGADLRPVLGDRRYSVVHVKNPQVTGILVHDDTLTGGTLIVGYRPEDGESLEDFTDDRCAELVGAAVGAPGVEVTIRSRFPWDMAEQVAESFVHGRVLLAGDAAHVVPPTGGYGANTGIADAHNLAWKLALVAAGVAGPGLVETYDAERRPVAVYTAEQGSLQLALRSGTATPEQQAAVADAVTVTSGQAYRSTAVVGEPDGADLPVASDPRELRGAPGTRAPYVELLRGGETVSTLDLFGRDFVLLTGEHGREWISAAVSASAGLGLKITARRVVPGTDAGAGTLADPDGDWSERYGGLRPEGAVLVRPDGVVAWRSPGADPGGEESAVLAAVLRSVLARESRTGGK	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	117.34	gnl|BL_ORD_ID|4834|hsp_num:0	5821			9	1359	rifampin
BGC0000266.1|Rubromycin_9 # 6976 # 7464 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.691	BGC0000266.1|Rubromycin_9 	6976	7464	-	Loose	280	29.6462	emrR	27.38	3000516	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGACACTTCGACTCAGCCCCCGCCCCGGGCAGCGGATCTGCTCGACGCCGTCGGCCCCGCCTTCTCCCGGCTGCGGCGTGCGCAGGCGCTGAACGTGGAGAAGCAGGTGTCCCGCAAGGACTTCACCAGGACGCTGGTCCTCAACATCGTCCAGGACGGGCCCGACCAGGAGGGTCAGGAGATCACCGTCGGTGTCGTGGGCGAGCGGCTCGCCGTCGACCCCTCCGTGGCCAGCCGGATGGTCTCCGACTGCATCTCCGCCGGCTATCTGATCCGTGCGGCCTCGCAGCGCGACGGCCGCCGTACGATCCTGCAGCTCACCCCGGAGGGGCACGAGACGCTCGCCCGCTTCCGGCGCCACCAGCGTGCGGCCTTCGAGCGCATCACTCAGGACTGGCCGGAGGAGGAGCGGCTCGAATTCGCCCGCCTGCTCATCAAGTACGTCGACTCCGTAGGCGAGTTGCAGCACGAGTCGGGTTCTGCCTGA	MDTSTQPPPRAADLLDAVGPAFSRLRRAQALNVEKQVSRKDFTRTLVLNIVQDGPDQEGQEITVGVVGERLAVDPSVASRMVSDCISAGYLIRAASQRDGRRTILQLTPEGHETLARFRRHQRAAFERITQDWPEEERLEFARLLIKYVDSVGELQHESGSA	MDSSFTPIEQMLKFRASRHEDFPYQEILLTRLCMHMQSKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHEFLREVLPPQHNCLHQLWSALSTTEKDQLEQITRKLLSRLDQMEQDGVVLEAMS	92.05	gnl|BL_ORD_ID|1225|hsp_num:0	1330			126	375	nalidixic acid
BGC0000266.1|Rubromycin_10 # 7614 # 9170 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGGGG;rbs_spacer=6bp;gc_cont=0.721	BGC0000266.1|Rubromycin_10 	7614	9170	+	Loose	600	366.311	Streptomyces venezuelae rox	46.39	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGTCCCAGTCCGTGCCACCCGAGCAGTCCGAACGCGACTTCGAGATCACCTACGACACCGACGTCGACTTCGACGTGCTGATCGTCGGCGGCGGTCCCGTCGGCATGCTGCTCGCCGCGGAGCTCCGGATCTCCCGCGTCCGGGCGGTCGTACTCGAACGGCTGCCCGAGCGCACCCCGCACTCCAAGGCCTTCGGGCTGCATGCCCGCTCCCTGGAATCCCTCGACCGGCGCGGCCTGCTCAAGCGGTTCCGCGAGGGAGCCCGGTCCTGGAACAACGGCCACTTCGCGGGCCTCGACGAGTGGGTCGACTTCTCCACCCTCGACAGCGCGCACGGCTACGCCCTGCTCTCCGAGCAGACCAGGACCGAGCGACTGCTGGAGGAGCGTGCCGCCGAGTTCGGCGCCGAGATCCGACGCGGTCACGAGGTCACCGCGATACGCCAGGACGCCGACGGCGTCGAGGCCGAGGTCGCCGGCCCCGACGGCACCTACACCCTGCGCGCCCGGTACGCCGTGGGCTGCGACGGCGGTCGCAGCCTGGTCCGCCGGGAGGCCGGCATCGACTTCCCCGGCACCGGCGGCCGGGTCACTGCCCGGCTCGGCGACGTGATCCTCGCCGACCGAGAGAACGCCCCCATGGGCATGGAGCGCACCGAACGCGGCCTGCTGTTCTGCGTGCCGCTGGACGACACCTACCACCGGGTCTCCACCTTCGACTTCGAGGCCGACCGCGAGCCCGGGGCGGAACTCACCCTGGAGGAGCTGACCGCCAGCCTGCGCGAGATCTGGGGCGACGACCTCGGTGCGCACTCGCCGCGCTGGCTCTCCGTCTTCACCGACTCCGCCTGCCAGGCGGACCGCTACCGCGAGGGCCGGCTGCTGATCGCGGGCGATGCCGCCCACACCCACTTCCCCGTCGGCGGGCAGGGCGTCAACCTCGGTCTCCAGGACGCCTTCAACCTCGGCTGGAAGCTCGCCGCCGAGGTGCACGGCTGGGCTCCCGAGGACCTGCTCGACAGCTACGACCGCGAACGCCAGGCGCCGGCCCGCAAGGTGCTGGCCAACACCCGCGCGCAGATCGCGCTGATGAACCCGGACCCCTACGTCACCCCGCTGCGCGAGCTCTTCACCGACCTCATGCGCAAGGAGCAGGTGAACCGGCACCTCGCCGAGATGCTCAGCGGCGTCACCGTCCGCTACGCGATCGACGGTCCCGAACACCGGCTGCTCGGCGACTTCGCCCGCGACCTGGAACTGAGGACCGAGGACGGCGTCAGGCCGCTCCCCAAGTACCTGAAGCGCGGCACCGGTCTGCTGCTCGACCTGACCGGCGACGGGCAGATCGGGCAGGTCCACGAGAAGTGGGCCGCGGGCGCCTCCTGGGCCGGCCGGCTCCAGCACGTCCGGGCCGAGTGCGCCGAGGAGCCGCAGCTGGCCGGTCTGCTGGTCCGCCCCGACGGCTATGTCGCCTGGGCCGCGGACCGGGACATGCCGGAGGCGGAGCTGCGCGAATCGCTGACCGCGGCCGTCACCACCTGGTTCGGCACCGACTGA	MSQSVPPEQSERDFEITYDTDVDFDVLIVGGGPVGMLLAAELRISRVRAVVLERLPERTPHSKAFGLHARSLESLDRRGLLKRFREGARSWNNGHFAGLDEWVDFSTLDSAHGYALLSEQTRTERLLEERAAEFGAEIRRGHEVTAIRQDADGVEAEVAGPDGTYTLRARYAVGCDGGRSLVRREAGIDFPGTGGRVTARLGDVILADRENAPMGMERTERGLLFCVPLDDTYHRVSTFDFEADREPGAELTLEELTASLREIWGDDLGAHSPRWLSVFTDSACQADRYREGRLLIAGDAAHTHFPVGGQGVNLGLQDAFNLGWKLAAEVHGWAPEDLLDSYDRERQAPARKVLANTRAQIALMNPDPYVTPLRELFTDLMRKEQVNRHLAEMLSGVTVRYAIDGPEHRLLGDFARDLELRTEDGVRPLPKYLKRGTGLLLDLTGDGQIGQVHEKWAAGASWAGRLQHVRAECAEEPQLAGLLVRPDGYVAWAADRDMPEAELRESLTAAVTTWFGTD	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	108.82	gnl|BL_ORD_ID|4833|hsp_num:0	5820			3	1413	rifampin; rifaximin; rifapentine
BGC0000266.1|Rubromycin_11 # 9322 # 10749 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.744	BGC0000266.1|Rubromycin_11 	9322	10749	+	Loose	900	83.9593	iri	40.0	3002884	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGGCCATCAGAGTGGCCGCCACCCTCGGACTCTCGGACCACATGGCCGCCGGAGCGGTCACGGTCGAGACGCTGGCCCGCGAGGCGGACGTGGACGCGATCGCCCTGGGCCGTCTCCTCGGTCACCTGGTGAACGCCGGGATCTACCGCCGGCTCCCCGACGGGGCCTACGAACCGACGGACCTCGGCGCCCTGTTGCGCGACGACCTCCCCCAGTCGGGCCGTGACTGGCTCCGCCTGGACGGCCCCACCGGCCGGGGCGAGGCGGCGGTGTTCCGCCTGCTCGATGCCGTGCGCTCCGGCGAACCCGTCTACTCCGCCCTGTACGGGCAGGAGTTCTGGACGGACGTCGAGTCGGACGGCGCGCTCGCCGAGGCCTTCGCCCGGCGGATGGCGGCGAGTATGCGCTGGGTCGTCCCCGAGCTGCTGGCCCAGGGCCACTGGCAGTCCGTACGGCACGTCGTCGACGTGGGTGGCGGAAGCGGTGACCTGCTCGCGGCCGTGGTCGACGCCACCCCGGGCGCGCGGGGCACGCTGCTCGACCTGGAGGCGCCCGCCGCCGCGGCCGAGCGGGACTTCACCGAGGAGCGCTGCACCGCCCTGGTGCGCGCCGCGGTCGGGGTGCCCGACCTGCCGCTGAAGATCGAGTCGGCGGACATGCCCGCGTGGGACATCTCCGCGAGGGTGGCGGACACCTTCGCGACCCGCCGGGTGTTCGTCGCCGGGGACGCCGCCCATGTGATGCCGCCGACCGGGGCGTTCGGCGCCAGCACCGGTATCCAGGACGCGTACAACCTGGCCTGGAAGTTGGCCCTGGTGCTCTCCGGCACGGCGGGTCCCGGACTCCTGGAGAGCTACGACGCCGAGCGGCGGCCGGTGGCCGAGGAGACCGTCCGGCAGGCGATGCTGCGGTTCGCGGTGCGGGAGGGCAAGCAGTACCAGGACGTCGCCGCGGAGCTGCTGGACGAGACGACCATGACGTTCGGGTACTGCTACCGCTCCGGGGCCTTCGCCGCGGAGGAGGGGGCGCCGGACGCCATCGTCGAGGACCCCGCGCACCCCTCGGCGCGGCCCGGGGCGCGGGCACCGCACCTCCAACTCGACGGGCCGGAAGGACCGGTTTCGGTCATCGACCTGTACGGCGACGGATTCACGCTGCTGGTCGACGAGGCGGCGGGACGGTGGACCGGGGCGGTGGAGCGGGAGGCCGAGCGGTTGGGTGTCGCGCTGAAGGTCGTACGGATCGGACGCGGGACGCGGCTGTGGGACCAGGACGGGTCCTTCCGGCGGCGGTACGGGCTGCTGGCCGGGGGCGCGGTTNTGNTACGGCCCGACGGGTTCGTGGGGTGGCGTACGACCGCGGGGCGCAGCGGGCCCGTCGACCAGGCGGCGATCGACGCGCTGCGGGGGGTGCTGGACCGGGTCTAG	MAIRVAATLGLSDHMAAGAVTVETLAREADVDAIALGRLLGHLVNAGIYRRLPDGAYEPTDLGALLRDDLPQSGRDWLRLDGPTGRGEAAVFRLLDAVRSGEPVYSALYGQEFWTDVESDGALAEAFARRMAASMRWVVPELLAQGHWQSVRHVVDVGGGSGDLLAAVVDATPGARGTLLDLEAPAAAAERDFTEERCTALVRAAVGVPDLPLKIESADMPAWDISARVADTFATRRVFVAGDAAHVMPPTGAFGASTGIQDAYNLAWKLALVLSGTAGPGLLESYDAERRPVAEETVRQAMLRFAVREGKQYQDVAAELLDETTMTFGYCYRSGAFAAEEGAPDAIVEDPAHPSARPGARAPHLQLDGPEGPVSVIDLYGDGFTLLVDEAAGRWTGAVEREAERLGVALKVVRIGRGTRLWDQDGSFRRRYGLLAGGAVXXRPDGFVGWRTTAGRSGPVDQAAIDALRGVLDRV	MSDVIIVGAGPTGLMLAGELRLQGVDVVVVDKDEEPTQFVRALGIHVRSIEIMEQRGLLDKFLAHGRKYPLGGFFAGISKPAPAHLDTAHGYVLGIPQPEIDRILAEHATEVGADIQRGKRVVAIRQDTDNVAAELSDGTTLHARYLVGCDGGRSTVRKLRSTSVFPASRTSADTLIGEMDVTMPADELAAVVAEIRETHKRFGVGPAGNGAFRVVVPAAEVADGRATPTTLDDIKQQLLAIAGTDFGVHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFNLGWKLAAEINGWAPVGLLDTYESERRPVAADVLDNTRAQAELISTAAGPQAVRRLISELMEFEDVKRYLTEKITAISIRYDFGEGDDLLGRRLRNIALTRGNLYDLMRSGRGLLLDQGGQLSVDGWSDRADHIVDTSTELEAPAVLLRPDGHVAWIGDAQAELDTQLSTWFGRSARDRA	99.16	gnl|BL_ORD_ID|729|hsp_num:0	796			780	1155	rifampin; rifaximin; rifabutin; rifapentine
BGC0000266.1|Rubromycin_12 # 10920 # 12497 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.745	BGC0000266.1|Rubromycin_12 	10920	12497	-	Loose	550	141.739	Nocardia farcinica rox	32.95	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGGCGGACGAGACGACCGAAGTACTCATCGTGGGCGGCAGCATGGTGGGGCTCGCCCAGGCCCTGTTCCTCGCCCGGCAGGGCATCCGGCCGGTGCTGGTGGAACGGCACGCCGAGATCTCGGCGCACCCCCGGGCGCAGGCCGCGAGCCCGCGGACCATGGAGCTGCTGCGCGCGCTCGGCCTGGAGGACGCGGTACGGGCACGGGAGAACCCGCACGCCCAGTACGGCGACATCCTCCAGGCCGAGTCCCTCACCGGGGCGGAACTCGGGCGGTTCGACGGGCCGTTCCGCTTCGACCGGCACGAGGTCGGCACCACCGGCTGGACACTGATCGGGCAGGACCGCCTCGAACCGGTGCTGCGGGAGCGGGCCGAGGAACTCGGCGCGGACATCCGGTTCGCCACGGAGATGACGGAGTTCACCCAGGACGCGGACGGCGTCACGGCCGTCCTGCGCGACCTGGGCGACGGCTCGGAGCGGACCGTACGGGCGCGGTACCTGGTCGCGGCCGACGGCTCACGGGCGCCGATCCGCACCTCGCTCGGCATCGGCCATCACGGGCAGGGCGTGTTCGGCCGGCAGATGAACATCGTCTTCCACGCCGACCTCGACCCCTACGTGGCGGGGCGCACCTTCTTCCTCTGCTTCGTCAGCAACCCGGCCGTCAAGGGCGTGCTCGGCAAGCTCGGCGGCGCGGACTCCGACCGCTGGGTGCTCGCGCCGAGCCTGCCGCCCGGGGCCGACCACCGCGTCTACGGCACCGAGGACTGCGTGGAGCTGGTCCGGGCCGCGGTGGGCGTGCCCGATCTGCCGGTCACGGTGGAGTCCGCGACGAGCTGGGAGATCGCCGCCTGGGTCGCGGACCGCTTCCGCTCCGGACGCGTGCTGCTGGCCGGCGACAGCGCCCACGTCATGCCGCCCACCGGGGGCTTCGGCGGCAACATGGGCATCCAGGACGCGCACAACCTGGCCTGGAAGCTCGCGCGGGTGCTGCGCGGACAGGCGGGCCCCGGCCTGCTGGACACCTACGAGCAGGAGCGGGCCCCGGTCGCCGAGTTCACCGTCGACCAGGGCGTCATCCGCTACCTCCAGCGCAGCGGCCTCGACGAGGCGGCCGCGGCCCGGCACCGGCCCGAGACCACGGTGCTGTTCGGCCACGTGTACCGGTCGGACGCCGTCCTCCGCGAGGCCGGGGACGACGACACCGCCGTGATCGAGGACCCGACGACGCCCACCGGCCGCCCCGGCACCCGCGCTCCCCACCTCCCCCTGGTCCGCCAGGGCAAGGACGTCGCCCTCCACGACCTCCTCGACGGCGACTTCTGGCTCCTCGCCGGCCCCGGCGGCATCGCCTGGCAGGAGCCGGCGGCCGCGCTCGGCCTGTCCTTCCACCGGGTGGGCGCCGAGGAGTCCCCCGCGGTCGTCGAACGGTTCCTCGCCCGCTACNGCNTCGAGGAGACCGGTGCGGTGCTGCTCCGGCCGGACGGGTTCATCGCGTGGCGTGCCGGTCGGGCGGAGGGTGATGCCGGCGGGTCGCTGCNGGCGGTGCTCGACGCGGTGTTGCGGCGTGCGTGA	MADETTEVLIVGGSMVGLAQALFLARQGIRPVLVERHAEISAHPRAQAASPRTMELLRALGLEDAVRARENPHAQYGDILQAESLTGAELGRFDGPFRFDRHEVGTTGWTLIGQDRLEPVLRERAEELGADIRFATEMTEFTQDADGVTAVLRDLGDGSERTVRARYLVAADGSRAPIRTSLGIGHHGQGVFGRQMNIVFHADLDPYVAGRTFFLCFVSNPAVKGVLGKLGGADSDRWVLAPSLPPGADHRVYGTEDCVELVRAAVGVPDLPVTVESATSWEIAAWVADRFRSGRVLLAGDSAHVMPPTGGFGGNMGIQDAHNLAWKLARVLRGQAGPGLLDTYEQERAPVAEFTVDQGVIRYLQRSGLDEAAAARHRPETTVLFGHVYRSDAVLREAGDDDTAVIEDPTTPTGRPGTRAPHLPLVRQGKDVALHDLLDGDFWLLAGPGGIAWQEPAAALGLSFHRVGAEESPAVVERFLARYXXEETGAVLLRPDGFIAWRAGRAEGDAGGSLXAVLDAVLRRA	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	110.99	gnl|BL_ORD_ID|4834|hsp_num:0	5821			6	999	rifampin
BGC0000266.1|Rubromycin_13 # 12699 # 13148 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=9bp;gc_cont=0.727	BGC0000266.1|Rubromycin_13 	12699	13148	+	Loose	750	25.409	tet(52)	34.15	3004587	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	GTGGTGGAGGCTTTGAGTGTGCTGGTGCTCACGGGCACCGGCCTGGTGGCGGGGGTGCTCTTCGCGGTCGCGGTGAGCGTGATGCCCGCGCTGATCGCGATGACCCCGGAGCGGTACGTGTCCACGCACATCCTGCTCGGCAAGCGCTACGACCGGATCATGCCGTTCATCGTCACCGGCTCCACGGCCGTGGACGTAGGGCTCGCGATACGGGCGTCGGAGGGCCCCCGGGTGCTGTTCGCGGCCGCCGCGGTCTGCATGGCGGGGGTGGCCGTGGTGTCGCAGACCCGGAACGTGCCGATCAACCGGCGGGTCAAGCGGACCCGGCCCGAGGACCTGGGCCCTGGCTGGCGGGACCCGCGCCCGGCCTGGCGGGACTGGCATCTGGTGCGCACCGGCCTCGCGATCGCGGGCTGCGCGCTGACCGCCGCTGCGGTGGTGCTGTCATGA	MVEALSVLVLTGTGLVAGVLFAVAVSVMPALIAMTPERYVSTHILLGKRYDRIMPFIVTGSTAVDVGLAIRASEGPRVLFAAAAVCMAGVAVVSQTRNVPINRRVKRTRPEDLGPGWRDPRPAWRDWHLVRTGLAIAGCALTAAAVVLS	MSNVNKILVIGAGIAGPAACYWLRRFGFSPVLVERSASLRKGGHALDVRGVAIDLVKRMGIYQKIYNMRTQLEFGRHVDPEGNTLHEEKGERFGFREGQDVEIIRSDLVEILIDSIEGVPLQFNQTIESVKQTDAVVEVQFKDGRTEHFDLVIGADGLHSTTRRIVFDKHEYKLNDLGAYFSVFSIPNYLNLNNTEVQCEANQKLLSITSDKNRKMAEVAFSFRGQNVLNNVRDESEQRRVLRDTFQDFGWEAPRILELMSDSDDFYSDSFTQVIMKSWTKGRVALLGDAAYSASPISGQGNNLALVGAYVLAGELKQAGGNYKRAFDRYNEILRPFIEANQKLGVLVNESFLVRDEVSKEVAEERSNNIMEQVKIASNMIVLQDYANPH	38.21	gnl|BL_ORD_ID|2698|hsp_num:0	3289			648	765	tetracycline; oxytetracycline
BGC0000266.1|Rubromycin_14 # 13145 # 13678 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.762	BGC0000266.1|Rubromycin_14 	13145	13678	+	Loose	750	25.7942	tet(X6)	39.02	3005056	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGAGCCCCGTCGTCGTACGCGAACTGCCGGAGGGCCCGGAGCGAGCGGCGGCCGATGCCCGGATGCGGGAGCTGCTGTCCCGTCCCGCGCCCGGCCCGGTGGCCGAGCGGCTCGCGCTGCTGCACTTCAGCGGCCGGCGCAGCGGGCGGCCGTACACCGTGCCCGCCGGGGTGCACACCCTCGGTGGCGCGCTGGTGGTGGCGACCGGCAGCGGCTGGCGGTACAACTTCGCGGGCGGCTCGCCGGGCGAGCTGACCTGGCGCGGACAGCGGCGGCCGGTGCGGTTCACGCTGGTCGACGACGCGGAGCGCAGCGCGCGCGGCTATCTGGAGCTGTACCGCCGCTACGGGGAGGAGGCCCCGCGCCGGCTCGGACTGGCGGTGCGCGGTGCGGGGACGCCCGCACTCGCCGAGTTCCGGGAGGCGGTCGGCCGGCACGGGCTCTCCCTGGTGGAGGTCACCCTCGTCACCCACGCCCCGGCGGAGAACAGCGCACCCCCATCAGACGCAGAGAGCGAAAGGACGCCACGATGA	MSPVVVRELPEGPERAAADARMRELLSRPAPGPVAERLALLHFSGRRSGRPYTVPAGVHTLGGALVVATGSGWRYNFAGGSPGELTWRGQRRPVRFTLVDDAERSARGYLELYRRYGEEAPRRLGLAVRGAGTPALAEFREAVGRHGLSLVEVTLVTHAPAENSAPPSDAESERTPR	MTLLKHKKITIIGAGPVGLTMARLLQQNGVDITVYERDKDQDARIFGGTLDLHRDSGQEAMKRAGLLQTYYDLALPMGVNIVDEKGNILTTKNVRPENRFDNPEINRNDLRTILLNSLQNDTVIWDRKLVTLEPDKEKWILTFEDKSSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKSKTRVDFQDRNSVVDFLLKKFSDWDERYKELIRLTSSFVGLATRIFPLDKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQAESIINETEMFSLDFSFQKLMNL	46.83	gnl|BL_ORD_ID|4802|hsp_num:0	3797			75	198	tetracycline; minocycline; oxytetracycline
BGC0000266.1|Rubromycin_15 # 13675 # 15546 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.733	BGC0000266.1|Rubromycin_15 	13675	15546	+	Loose	500	28.4906	AxyX	32.43	3004143	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCGGAATCGCCGGCTGGGTGGACTTCGAACGGGACCTGACACCGGAGGCCCCCACCGTACGGGCGATGGCGGCGGCGCTCGCGCACCGCGGCCCGGACGGCTTCGGTGAGTGGATCGAGGGCCATGCCGCACTGGCCCACCGGCGGCTCTCCCTGATCGGCTCCGAGCACGCGGGGCAGCCGGCCATCGTGGAGTCGGAGGCCGGGAGCCCGGTGGCCGTGCTGACCCTGGACGGGAGCGTCACCAACGCGGTGGAGCTGCGCCGCGAACTGGCGGCGAAGGGGCACCGGTTCACCGGGGACGGTGACGCGGAGGTGGCGCTGCACGCCTACCTGGAGTGGGGTGCCGCGTTCCCCGAGCGGCTGGAGGGCCTGTTCGCGCTGGCCGTGTGGGACGTGCGGCGGCAGGAACTGCTGCTGGTCCGCGACCGGTTGGGGGTGAAGCCGCTGTGCTACTTCCTGACGCCGTCCGGTGTGGTCTTCGGCTCCGAGCCCAAGGCGCTGCTGGCCCATCCGGCGGTCCGGCCGGTGGTCGACGCCGACGGGCTGCGGGAGCTGTTCGCGCACAGCCGCAAGCCGGGCACCGGGGTGTTCCGGGGCACGCGCGAGGTGCTGCCCGGCCACACGATGACCGTGCGGGCGCCGGGCACCGGCCACCGCCGCTACTGGTCGCTGCCCGCCCGCCCGCACACCGACAGCCTGGAGACCACCGTCGCCACCGTGCGCCGGCTGCTGTCGGAGGCGGTCGCCACGCATCTGCGTGCGGACGTGCCGGTCGGCGCGATGCTCTCCGGCGGGATCGACTCCAGCGCGCTGACCGCGCTCGCGGCCCACCGGCGGCGGGCCGAGGGGGCCGGCCTCCGGTCGTTCTCGGTGAACTTCTCCGGCTACGCGGAGAACTTCGAGCCGCACCCGACCATGCGCGCCACCCCCGACGCCCCCTACGCGGCTCTCGCCGCCGAGCACATCGGGACCGAGCACACCGAGATCCTGCTGGACACGGCGGCGCTCGCCGATCCGGGGACGCACGCCGCCGCTCTGCGCAGCCAGGACGCGCCCTCGCCGCTCGGTGACATGGACGTCTCGCTGCTGCTGTTCTTCGAGGCGCTGCGCGGCGCGGGGATCACCGCGGTGCTCTCCGGGGAGACCGCGGACGAGGTGTTCAACGGCTACTTCTGGGCGTACGACCCGGGCCACAGCAACTCCACGACCTTCCCGTGGGTCTCCTTCGAGCGCGGGCACGACGCCGCCGCGGGCGGTCTCGGCTGCTCGCTGGTGGACCGTACGCTCCGCAAGGAGCTGGACTTCATGGACTACGCCGACCAGCACTACCGCGACGCGCTCACCGAGGTCCCGCAGGTGGCCGGCGAGAGTCCTGCCGAGCGCAGGGCGCGCGAGGTCACGTATCTGGCGCTGACCCGGTGGGCCCCGACCCATCTGGACCGGGCCGACCGGATGAGCATGGCGCACGGGGTGCAACTGCGCCCGCCGTTCTGCGACCGGGCGCTGGTGGAGTACGTCTACAACGTCCCGGCCGAGTTGAAGCGCGTGAACGGCCAGGAGAAGAGCCTGCTGCGGGCCGCGGTCGCCGATCTGCTGCCGGAGCGGGTGCTCAACCGGCCCAAGAGCGCCTATCCGACCGTGCAGGAGGCGGCGTACGGCGAGTTCGTGCGCCACCGCTTCGAGGACGTGGCCGCGGACCGCACGGCGCCGGTCGCCCCGCTGCTGGACGCCGAGGCGACCCGGGTGGCCCTTGGTGCGGCGGCTGCTCCCAGCGGTGCCTTCGCGTGGGTGGAACGGGCGAGCATGGAGATGGTGCTTCAGCTGAACACGTGGCTCTCGGAGTACGGGGTCGAGCTGCGGGTGTGA	MSGIAGWVDFERDLTPEAPTVRAMAAALAHRGPDGFGEWIEGHAALAHRRLSLIGSEHAGQPAIVESEAGSPVAVLTLDGSVTNAVELRRELAAKGHRFTGDGDAEVALHAYLEWGAAFPERLEGLFALAVWDVRRQELLLVRDRLGVKPLCYFLTPSGVVFGSEPKALLAHPAVRPVVDADGLRELFAHSRKPGTGVFRGTREVLPGHTMTVRAPGTGHRRYWSLPARPHTDSLETTVATVRRLLSEAVATHLRADVPVGAMLSGGIDSSALTALAAHRRRAEGAGLRSFSVNFSGYAENFEPHPTMRATPDAPYAALAAEHIGTEHTEILLDTAALADPGTHAAALRSQDAPSPLGDMDVSLLLFFEALRGAGITAVLSGETADEVFNGYFWAYDPGHSNSTTFPWVSFERGHDAAAGGLGCSLVDRTLRKELDFMDYADQHYRDALTEVPQVAGESPAERRAREVTYLALTRWAPTHLDRADRMSMAHGVQLRPPFCDRALVEYVYNVPAELKRVNGQEKSLLRAAVADLLPERVLNRPKSAYPTVQEAAYGEFVRHRFEDVAADRTAPVAPLLDAEATRVALGAAAAPSGAFAWVERASMEMVLQLNTWLSEYGVELRV	MTHRVPFRTLAFASVLVLVSACSKQEAPEAAKAPAEVGVIVARATPTAVASELPGRLEPYREAEVRARVAGIVTRRLYEEGQEVTRGTPLFQIDPAPLQAAYDSEAAALARAQANLSAAADKLRRYADLVSDRAISERDHAESVAQERQARAEVALAKANLQSARLRLEYARVTSPIDGRARRALVTEGALVGEGQATPLTVVQQLDPIYVNFSQPAAEVMQLQKQIRAGALQGVAPDKMRVRLLLPDGSEYGQGGTLSFADLAVDPGTDNVTMRALFANPGRELLPGMYVRVRLEQAVNRDTFLVPRNALLRNADGAHVLVAGDDGELRSVAVTAHRLLGPNWVVTEGLAGGERVVVENAAQLAPGQKIKPVERTAPSAPVATAGNNEKR	159.34	gnl|BL_ORD_ID|2409|hsp_num:0	2797			729	921	erythromycin; cefepime
BGC0000266.1|Rubromycin_16 # 15807 # 17792 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GGAAG;rbs_spacer=11bp;gc_cont=0.720	BGC0000266.1|Rubromycin_16 	15807	17792	+	Loose	400	29.261	cprR	32.65	3005063	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration; antibiotic efflux	pmr phosphoethanolamine transferase	ATGGCCGCCACCCACACAGGCGGCTCACTCAGGGGGAATGCAGTGATAGAGATCGGTCTGCTGGGCTCCATGCGAATACGCAGGAACGGGGAGGACGTCACACCGTCCGCCCCCAAACTGCGTCAGGTGCTGGCCCTGCTGGTGCTCAATGCCAACTCGCTGGTCAGTGTGGACCAGCTGTGCGAGGAGCTGTGGGAGGACCACCCGCCGCTCAGCGCGCTGACCACCTTGCAAACCTACATTTATCAACTGCGCCGCAGACTGCTGCTGGCCACCGGCCAGCACGGCGCGGCTTTCGGCTCCCGTCCACCGCACGGCTGCCCCGCAATCCTGACCAGGGTCGGCGGCTATGAACTGCGCCTGGACGACAAGCAGTCGGTGGACGCCTACCGGTTCGACCAGCTCATAGAACAGGGCATGGCACAACTCCGCACCGGCGCGGGGGAGGAAGAGGCGGCCCGCACCCTCAAGGCGGCCCTTTCCCTGTGGCAGGGCGGAGCCCTGGTCGACGTCAGCACCGGACGCCGGCTGTCGGCCTGGTCGACCCAGTTGGAGGAACGCCGTAAGAGCGTCCTGGAGCAACGTTTCTCCCTGGAGCTCCAACTCGGCCGTCACCACACCGTCCTGGACGAACTGTCGGAGGCCTTCCGGGCCCACCCCACCCACGAGGCGTTCGCCGGCCAACTGATGCGGGCCCTGCACCGCTGCGGCCGCCGCCCGGACGCCCTCAACACCTTCCGCACCCTGCGCAGCCATCTCGTCGAGGAACTCGGCCTGGAACCCTCCGTGCAGCTCCAGCGGCTCCACCAGGAGGTGCTCGCGGACCGCGGCCACCTCCGAGGGCCCGCCCCGGCCAAGGCCGAGACCGTGTCGGGCGGACGCCGGCTCGTGCCGNGGCCGGCCCAGCTCCCCGCCGACGTCGGTGACTTCGTCGGGCGGGAACGCGAACTCGACCAGCTGGAGACCTTCCTCGGCGCGGACCGGCCCAGCACCGGCATGCGCGTGGTGGAGGTGCACGGCCCGCCCGGGGTCGGGAAGAGCGCCTTCGCCGTGCGTGCCGCGCACCGGCTGCGCCCGCGCTTCCCGGACGGACAGCTCTTCATCGACCTGTCCGCCGTCGGCGAGGGCTCCCAGCAACTCGCGGACGTGCTCTCGGCCTGCCTCACCGCCTGCGGCATCCAGCGCGAGAAGCAGCCCAGCGGGCTCGGCGAGCTCAGCAGGCTCTTCCGCACCTGGACCGCCGACCGCCGGGTGCTGGTCGTGGTCGACGACGCCCTCACCGCCTCCCAGATCCGCGCCGTCCTGCCGGGCGGCTCCGGCTGCGCGGTGATCGCCACCAACCGCTACCGCGCGCACAGCCTGTCCACCGGCCGCAAGATCGTGCTCCCGGCCCTGTCCCCGGAGGAGTCCCTCCAGCTCTACGACCGGGTCGCCGGGGAGCGCTCCCGGCAGGAGGACCCCGGGGCGGTGCAGGAGCTGATAGGGCTGTGCGAGGGGCTGCCCCTGGCGATCAGGGCCGTGGCCGGCCGGCTCACCGCGCGGCCCGGCTGGTCGGCGGCCCGGCTGGCGTCGCGGCTGCGCGGCAACCACCGGATGCTGCTCGAACTGCCCGCCGGTACCCAGTCGCTGATGACCACCGTGGCCGCGAGCCACCGGCATCTGCCCGCCCGCTCACGGGAGTTGCTGCGCCTGCTGCTCCAGCGCGAGCGCCCCCGCTGGAGCCTCGACGAGGTGGTGACACGGCTGCGTCCCGGCAGCGGAGACGCCGAGACGCTCCTCGAATACCTCGTCGACGTCCACCTCGTCCAGGAGCACCTGACACCGGACGCCGAGCTCCTGTACTCCGTGCCCCGGCTCACCCGGCAGGCCCTGATCCTCCTGTCGCGGGGCACGCCCGCGGGCGACGTACCGAACGGCCGGATGGTCGGCGCCGGTGTCGTCGCCGGCACCGGCGTCACCCTGATGAAGGCCGACGTCCGCCGCTAG	MAATHTGGSLRGNAVIEIGLLGSMRIRRNGEDVTPSAPKLRQVLALLVLNANSLVSVDQLCEELWEDHPPLSALTTLQTYIYQLRRRLLLATGQHGAAFGSRPPHGCPAILTRVGGYELRLDDKQSVDAYRFDQLIEQGMAQLRTGAGEEEAARTLKAALSLWQGGALVDVSTGRRLSAWSTQLEERRKSVLEQRFSLELQLGRHHTVLDELSEAFRAHPTHEAFAGQLMRALHRCGRRPDALNTFRTLRSHLVEELGLEPSVQLQRLHQEVLADRGHLRGPAPAKAETVSGGRRLVPXPAQLPADVGDFVGRERELDQLETFLGADRPSTGMRVVEVHGPPGVGKSAFAVRAAHRLRPRFPDGQLFIDLSAVGEGSQQLADVLSACLTACGIQREKQPSGLGELSRLFRTWTADRRVLVVVDDALTASQIRAVLPGGSGCAVIATNRYRAHSLSTGRKIVLPALSPEESLQLYDRVAGERSRQEDPGAVQELIGLCEGLPLAIRAVAGRLTARPGWSAARLASRLRGNHRMLLELPAGTQSLMTTVAASHRHLPARSRELLRLLLQRERPRWSLDEVVTRLRPGSGDAETLLEYLVDVHLVQEHLTPDAELLYSVPRLTRQALILLSRGTPAGDVPNGRMVGAGVVAGTGVTLMKADVRR	MHIHVLVVEDNFDLAGTVIDYLEAAGVVCDHARDGQAGLNLARANRYDVILLDIMLPRINGRQVCRQLREAGLQTPVLMLTALDTLQDKLDGFDAGADDYLLKPFELPELLVRLQALSRRRSGQAQRLQVDDLVMDLDSRQASRGGTPLALSPTAWKILECLMRASPALVTREQLGRSVWGDEPPESNTLNVHMHHLRSTVDKGFATPLIHTLHSVGFQLERK	296.41	gnl|BL_ORD_ID|2788|hsp_num:0	3803			453	594	polymyxin B; colistin A; colistin B
BGC0000266.1|Rubromycin_20 # 20032 # 21300 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.763	BGC0000266.1|Rubromycin_20 	20032	21300	+	Loose	750	105.531	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	36.55	3003463	protein variant model	G387D, F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGAGCGCCTCCGGCATCAGCCCCGGCCGGCGCGGCCGGTCCGTGGTCACCGGGCTCGGCGTGGTCGCGCCCACCGGGATCGGAGCCGTCCGGCACTGGGAGTCGGTGCTCTCGGGGAAGAGCGGCCTCGGCCGCATCACCCGCTTCGACCCGACCGGCTACCCCGTCCGGGTGGCGGGCGAGGTCCCCGGATTCCACGCCGGTGAACAGGTGCCGGGACGGCTCGTCCCGCAGACCGACCGCTTCACCCACTTCGCGCTGGCCGCCGCCGAGGACGCCCTCGCGGACGCCGCCGCCGACCCGGCGACCCTGCCGGAGTACGAGATGGCGGTGGTGACCGCCAGCTCCTCGGGCGGCACCGAGTTCGGACAGCACGAGATGGAGAACCTCTACCAGAAGGGGTCCTCCTGGGTCGGGGCGTACCAGTCCATCGCCTGGTTCTACGCGGCCACCACCGGCCAGGTCTCCATCCGGCACGGCATGCGCGGCCCCTGTGGGGTCATCTGCGGCGAGCAGGCCGGCGGTCTCGATGCCCTCGGCCAGTCCCGGCGGCTGCTGGACACCGGCTCCCGGCTCGTGCTCAGCGGTGGCACCGACGCCTCGCTGTGCCCGTACGGCCTGGTGGCGCAGCTGTCCACCGGCCGGCTGTCCACCGAGGACGATCCCGCCCGCGCCTACCTGCCCTTCGACGCGGCCGCCTCCGGCTTCGTCCCGGGGGAGGGCGGTGCCATCCTCGTCGTCGAGAACGCCGAGGGGGCACACGCCCGCGGGGTCCCGGCGTACGGCGAACTCCTCGGCTACGCGGCCGGTTTCGACCCCACCGCGGACGGCACCACCACGGGCCACTCCGTGCTGGTGTCCGTCGTGCGGCGGGCCCTCGCCGACGCAGGGCTCGCCCCGGGCGACGTCGACGTGGTCTTCGCCGACGCCTCCGGCACCCCCGCCGAGGACCTCGCCGAGGCCCGCGCGATCACCGAGGTCTTCGGGCCCGGCGGCGTGCCGGTGACCGCGCCGAAGACCCTCACCGGGCGCCTCTACGCGGGCGGCGCCGCCCTGGACGTGGCGACCGCGCTGCTCGCCCTGAGCGCCGGTGTCGTCCCGCACACCGCGGGGCTCGGCCGCCCGGCCCCCGGCTGCGAGATCGACCTCGTCCTCGACCGCCCCCGCCAGACCGACCCGCGCACCGCCCTGGTCCTGGCCCGCGGGCACGGCGGCTTCACCTCCGCCCTGGTCCTCGGCGCGGGCGACCGCGGCGCCCCCGGCAAGTGA	MSASGISPGRRGRSVVTGLGVVAPTGIGAVRHWESVLSGKSGLGRITRFDPTGYPVRVAGEVPGFHAGEQVPGRLVPQTDRFTHFALAAAEDALADAAADPATLPEYEMAVVTASSSGGTEFGQHEMENLYQKGSSWVGAYQSIAWFYAATTGQVSIRHGMRGPCGVICGEQAGGLDALGQSRRLLDTGSRLVLSGGTDASLCPYGLVAQLSTGRLSTEDDPARAYLPFDAAASGFVPGEGGAILVVENAEGAHARGVPAYGELLGYAAGFDPTADGTTTGHSVLVSVVRRALADAGLAPGDVDVVFADASGTPAEDLAEARAITEVFGPGGVPVTAPKTLTGRLYAGGAALDVATALLALSAGVVPHTAGLGRPAPGCEIDLVLDRPRQTDPRTALVLARGHGGFTSALVLGAGDRGAPGK	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	101.44	gnl|BL_ORD_ID|1968|hsp_num:0	1943			546	1242	isoniazid
BGC0000266.1|Rubromycin_21 # 21339 # 21602 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.693	BGC0000266.1|Rubromycin_21 	21339	21602	+	Loose	1200	25.0238	LRA-13	28.21	3002484	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	class C LRA beta-lactamase; class D LRA beta-lactamase	ATGGCGGAGTTCACCCTCGACGACATCCGGCGGATCCTGCGCGCGAGCGGCGGGGTCGACGAGCAGACCGACCTGGACGGCGAGCACTTCGCCGACACCTCGTTCGCCGACCTCGGCTACGACTCCCTGGCCCTGCTGGAACTCGTCAACCGCATCGAGCGCGAGTACGGCATCCAGATCCCCGACGGCGACCTCTCGCACACCCAGACCCCGCGCGAGGCCCTGACCTATGTCCACGCCCGGCTTACGGAGGCCCGCGTCTGA	MAEFTLDDIRRILRASGGVDEQTDLDGEHFADTSFADLGYDSLALLELVNRIEREYGIQIPDGDLSHTQTPREALTYVHARLTEARV	MNFRHIVMAALCGLAWTPAIHATEVCIAIAEAGTGAVLVQRGDCQRQVTPASTFKIAISLMGYDSGFLKDAHAPKLPFRPGYVDWRPSWREPTDPAKWMSDSVVWYSQQVTKSLGMQRFADYTRNFKYGNADVSGDAENDGLSMSWISSSLRISPLEQLAFLDKIVNRRLGVSAHAYDMTAQLTKFDQPPAGWRINGKTGAASGYGWYVGWASKGSRTFVFAHLMQRDATQPQDVSAGVLARDEFLKELPGLMIKDMVDRAVQPLMKKYDIPGMAVAVTDNGKNYFFNYGLASRETGQAVTSHTLFEIGSLSKTMAATLTSYAQVNGQLALTDTVSRHMPKLRGGGFDKISLLNLGTHTAGDFPMQVPDHIETYEQLMEYYKNWKPGVAAGGARTYSNLTVGLLGIITAQSMGMPFAEAMENRLFPQLGMHHSYINVPAAEMKNYAQGYNQANAPVRINPAVLATEAYGVKTDAADLIRFVDANMGLVKLDEKLQRAVTGTHTAYFKTGELTQDLIWEQYPAASKLDRMLAGVSEKMVFESNPATRLAPPMPPQADVLINKTGSTGGFGAYALFNPGKKTGIVMLANKSYPGAERVTAAWHILDQLDQR	14.29	gnl|BL_ORD_ID|1764|hsp_num:0	1912			1035	1140	
BGC0000266.1|Rubromycin_22 # 21602 # 22798 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=10bp;gc_cont=0.723	BGC0000266.1|Rubromycin_22 	21602	22798	+	Loose	450	81.6481	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	29.76	3004045	protein variant model	F203A	n/a	disinfecting agents and antiseptics; isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant fabI	ATGGCAGGACACACCGACAACGGGATCGTCGTCGAGGCACCGATGGACCTGGTGTGGACGATGACCAACGACGTGGCCGCCTGGCCGCGGCTGTTCAACGAGTACGCCTCCGCCGAGATCCTCGGCCGGGACGGCGACACCGTCACCTTCCGCCTCGCCCTGCACCCGGACGAGAACGGCACGGTCTGGAGCTGGGTCTCCGAGCGCACCCCCGACCCGGCCACCCGCACCGTCGTCGCCCGCCGGGTCGAGACCGGCCCGTTCGCGCACATGAACATCCGCTGGGAGTACGAGGAGGTGCCTGGCGGCGTACGGATGCGCTGGATCCAGGACTTCGCGATGAAGCCCGACGCCCCGATCGACGACGCCGGGATGACCGCCCGGCTCAACCGCAACACCGCCGTCCAGATGCGGCTGATCAAGGCCAAGGTGGAGACCGCGGCCCGGGCCGGCCGGCAACTCCAGGGCAAGCGCATCCTGGTGACGGGCGGCAGCCGCGGCATCGGCAGGGGCATCGTCCTCGCCGCGGCCCGGGCCGGAGCCGACGTCGTCACCTGCTACCGCACCCCCGGCGAGGCCGTCGCCACGTTGGAGGAGGAACTCGCCGGCACCCCCGGCAAGCACCAGGTGCTGCGGGCCGACGCCGCCGACGCGACGGACGTGGACCGGCTGGCCGCCGCGTGCGAGGCGAGCCCCGGCGGACTGGACGCGGTCGTCAACAACGCCGGGACGTTCCGCCCCCAGCCGTACACCGACCTCGGACCCACCGAGTGGGCCGACACCCTCCAGGGCAACCTCACGGCCACCCACCTGGTCACCCGGCGCACCCTGCCGCTGCTCTCCGCCGGATCCTCGGTGGTCAACATCGGCTCCACGGTCGCCTTCATCGGCATGGCGGGCGGCGTCCACTACACCGCCGTCAAGTCCGCACTGGTCGGCATGACCCGCTCGCTGGCCCGGGAACTCGGACCGCGCGGCATCCGCGTCAACACCGTCTCACCCGGCCGCATCGCCACCGAGGCGCTCGACGAACTGCCCCCCGAGGAGGCCGAGCGCCAGCGCGCCACCTTCGCCTCCTTCACCGCGCTCGGCCGGCTCGGCACCGTCGACGACATCGCCCGGACCGTGCTGTTCCTCATCAGCGACCACGCCGGCTACGTCACCGGCCAGAACATCCACGTCGACGGCTGCGTCTGA	MAGHTDNGIVVEAPMDLVWTMTNDVAAWPRLFNEYASAEILGRDGDTVTFRLALHPDENGTVWSWVSERTPDPATRTVVARRVETGPFAHMNIRWEYEEVPGGVRMRWIQDFAMKPDAPIDDAGMTARLNRNTAVQMRLIKAKVETAARAGRQLQGKRILVTGGSRGIGRGIVLAAARAGADVVTCYRTPGEAVATLEEELAGTPGKHQVLRADAADATDVDRLAAACEASPGGLDAVVNNAGTFRPQPYTDLGPTEWADTLQGNLTATHLVTRRTLPLLSAGSSVVNIGSTVAFIGMAGGVHYTAVKSALVGMTRSLARELGPRGIRVNTVSPGRIATEALDELPPEEAERQRATFASFTALGRLGTVDDIARTVLFLISDHAGYVTGQNIHVDGCV	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	151.91	gnl|BL_ORD_ID|4712|hsp_num:0	2666			9	747	triclosan
BGC0000266.1|Rubromycin_23 # 22829 # 23578 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=GGGA;rbs_spacer=6bp;gc_cont=0.717	BGC0000266.1|Rubromycin_23 	22829	23578	+	Loose	500	53.9138	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid	25.1	3003393	protein variant model	V78A	n/a	isoniazid-like antibiotic	antibiotic target alteration	isoniazid resistant inhA	ATGGAACTCGCACTGCACGGCAGGAAACTGCTCATCACCGGCGGCACCCGGGGCATCGGGCGGGGCATCGTCCTCGCCGCGGCCCGGGCGGGCGCCGACGTCCTCACCTGCTACCGGCAGGAGAGCGAGGCCGTCGACAGCCTGACCGCCGCGCTGAAGGAGACCGCCGGCGACCACCACGTGATCCGCGCGGACGTCGGTGACACCGCCGAGGCCGACCGCCTCGTCGGCGAGGCCAAGGACCGCTTCGGTCGCCTCGACGGCGTGGTCAACAACGCGGGCGTGATCAGCCACATCCCGTTCGGGGAACTGCCGGCCGACGAGTGGTCGCGCATCCTCGACACCAACCTCACCGCGGCCTACCGGATCATTCACCAGGCGCTGCCGCTGCTCGGCACCGGCTCCTCGGTCGTCAACATCGGCTCGCGCGGAGCCGCCGCGGGCATACCACTGCGCGCCCACTACACCGCCGCGAAGGCCGCCATGATCGGGCTGACCCGTTCCCTCGCGAAGGAACTCGGCCCGAAGGGCATCCGGGTCAACGTGGTGGCCCCCGGCGTCATCGAGACCGAGGCCTTCGCCGACATGCCCGCCGAGCGCGCCGCCGGACTGCGCGCCACCTACTCCCAGAAGACCGCCCTGGCCCGCCTCGGCACCGTCGAGGAACTCGCCGGACCGGTGCTGTTCCTGCTCTCCGACGCCGCCGCGTACATCACCGGCGAGACCCTCAACGTCGACGGGGGGATCTGA	MELALHGRKLLITGGTRGIGRGIVLAAARAGADVLTCYRQESEAVDSLTAALKETAGDHHVIRADVGDTAEADRLVGEAKDRFGRLDGVVNNAGVISHIPFGELPADEWSRILDTNLTAAYRIIHQALPLLGTGSSVVNIGSRGAAAGIPLRAHYTAAKAAMIGLTRSLAKELGPKGIRVNVVAPGVIETEAFADMPAERAAGLRATYSQKTALARLGTVEELAGPVLFLLSDAAAYITGETLNVDGGI	MTGLLDGKRILVSGIITDSSIAFHIARVAQEQGAQLVLTGFDRLRLIQRITDRLPAKAPLLELDVQNEEHLASLAGRVTEAIGAGNKLDGVVHSIGFMPQTGMGINPFFDAPYADVSKGIHISAYSYASMAKALLPIMNPGGSIVGMDFDPSRAMPAYNWMTVAKSALESVNRFVAREAGKYGVRSNLVAAGPIRTLAMSAIVGGALGEEAGAQIQLLEEGWDQRAPIGWNMKDATPVAKTVCALLSDWLPATTGDIIYADGGAHTQLL	92.57	gnl|BL_ORD_ID|1964|hsp_num:0	1574			12	789	isoniazid
BGC0000266.1|Rubromycin_24 # 23580 # 23906 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=GGGGGG;rbs_spacer=7bp;gc_cont=0.670	BGC0000266.1|Rubromycin_24 	23580	23906	+	Loose	1850	24.6386	mdtF	34.62	3000796	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCCGAGCCCACCGAGAAGGTCTTCCGGGTCATGCTGCGCATGCAGATCAAGTCCGGCATGGAGCACGAGTTCGAGAAGGTGTGGCTGGAGGTCGGCGACTCGGTCACCACCCACCCCGCCAACCTCGGCCAGTGGCTGTCCCGCAGCGCCGAGGAGGACGGCATCTACTACATCGTCAGCGACTGGGTGGACGAACCGCTGTTCCGCGAGTTCGAGACCAGCGACCGCCATCTGGAGCACCGCCAGAAACTGCACCCCTACCGCAGCGGCGGCTCCATGACGACCATGCACGTCGTCGCCGCCCTGGCCGGCGCCGCGTCGTGA	MPEPTEKVFRVMLRMQIKSGMEHEFEKVWLEVGDSVTTHPANLGQWLSRSAEEDGIYYIVSDWVDEPLFREFETSDRHLEHRQKLHPYRSGGSMTTMHVVAALAGAAS	MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITVSATYPGADAQTVEDSVTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPEAVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGSEYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRLQTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLAAGANALDTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIEISIQEVFKTLVEAIILVFLVMYLFLQNFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVIAEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLLSVFVAMSLTPALCATILKAAPEGGHKPNALFARFNTLFEKSTQHYTDSTRSLLRCTGRYMVVYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKEKDNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAVVFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPNQVTGVRPNGLEDTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRMLPDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMKFMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVMLVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPIEAIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFVPVFFVVVEHLFARFKKA	10.41	gnl|BL_ORD_ID|103|hsp_num:0	121			2298	2376	erythromycin; cloxacillin; oxacillin; norfloxacin
BGC0000266.1|Rubromycin_25 # 23903 # 24256 # 1 # ID=1_25;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.726	BGC0000266.1|Rubromycin_25 	23903	24256	+	Loose	500	24.2534	Laribacter hongkongensis ampC beta-lactamase	52.38	3004292	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	ampC-type beta-lactamase	GTGACCGGCGGCGCCATCGAGGTGGTGCTCTACCACCTGAGCGACGAACCGGACCTGGTGCTGCCCGCGTACCACGAGGCCAGCCGCCGGATGGCGGGCACCGCCGGCCTGCTCGGCAACAAGCTGTTGCACGCCCTCGGCGACCCGCGCTCCTACGTCGTGGTCAGCCGCTGGTCCGACTGGGAGGCGTTCACCGCCTGGGAGAGCGGCTCCGCCCACAAGGACCAGACCGCACCGCTGCGTCCGCTGCGCGACACCGGCCGGGACCGGCCCTTCGAGATCTACCGGGAGCTCGCCAGCTACCCGGAGGGCCGGGCCGCCACCCCCACCGCCGACGTCAAGGAAGGAGTCTGA	MTGGAIEVVLYHLSDEPDLVLPAYHEASRRMAGTAGLLGNKLLHALGDPRSYVVVSRWSDWEAFTAWESGSAHKDQTAPLRPLRDTGRDRPFEIYRELASYPEGRAATPTADVKEGV	MKKRITPFSRFASKGLFACSAGMLLVTVAHAANTAAAPAGMDAMVQTVMQAHQIPGMAIAIIQPGKTTYHNYGVASRETGQPVRETTLFEIGSLSKPFTALVAQRAETEGRIDLSAPASRYVAALRGSAFDRITLRQLGTYSAGGLPLQFPDNVTTPADVLAYYQHWQPVHPAGTTRLYSNPSIGLMGLAASQATGESFAGLLGTTVLHPLGMNSTYLQVPPEARSRYAMGYTAAGKAVRVSPGPLDEETYGVKSTTADMAGFLLAHMDPARSKGALQSALQQTRVPVYCAGQTRQGLGWESYQDWKNLDVLLAGNSNQMVFEPQPVKACPAGTMNDPDVWVNKTGSTAGFGAYAVFLPARQTGIVILANRNFPIADRIRLAHGILTALH	30.00	gnl|BL_ORD_ID|2433|hsp_num:0	2845			597	660	
BGC0000266.1|Rubromycin_26 # 24259 # 25518 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.722	BGC0000266.1|Rubromycin_26 	24259	25518	+	Loose	850	26.9498	OpmH	36.84	3003682	protein homolog model	n/a	n/a	disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCACGCACGGACGCCCCGCAAGCAGCCCCGCCCGCCGACCTGTTCACCCCCGCCTTCCACCAGAACCCGCACGAGGCGCTGGCCGGCCTGCGGCGCACCGCGCCCGCCGTGCCCGTCATGACACCCAATGGCCTGCGCACCTGGCTGGTCACCGGACACGAGCACGCCCGGGCACTGCTGGCCGATCCCCGGCTGAGCAAGGACATGCGGGTCGGCCGGGACCTCATTCCGCGGAACTTCGTCGATCCCGACAAGCAGCGGGAGTTCCTCGCGGAGTCGGGGGAGCGCAGCCAGTTCCCGCACGTCCTCAGCGTGCACATGCTGGACAGCGACCCGCCGGACCACACCCGGCTGCGCCGGCTCGTCGGCCGGGCCTTCACCGCGCGACGGGTCGAGTCCCTGCGGCCGCGCATCACCGAACTCACCGACGAACTGCTGGACGCCATGGCCCGGCACGAGCGGCTGGACCTCATGGAGGCCCTGGCCTTCCCCGTGCCGTTCACGGTCATCTGCTGGCTGCTCGGCGTCCCCCCGGACGACCGGGCCGCGTTCCGCCGCTGGTCCAACCTGCTCGTCTCCGGCGCGGGCACCGACGAGGTACGCGAGGCCAGCGCGTCGATGATCACGTACCTGACGGAGCTGATCGAGGCCAAGCGGAACGAGCCGGCCGACGACATGCTCACCGACCTGGTGCACGCCCGGGACGCCGGCGACCAGCTGTCGTCCGACGAGCTGATCTCCATGGCGTTCCTGCTGCTGGTGGCCGGCCACGAGACCACGGTCAACCTCATCGGCAACGGCGCCCTGGCCCTGCTCACCCACCCCGAGGTGCGCGAGCAGCTCGCGGCGGACGAGTCGCTGTGGCCCGGGGCCGTGGAGGAGTTCCTCCGCTACGACGGCCCGGTCACCAACGCCACCTGGCGCTTCACCACCGAACCCGTCGAGGTCGGCTCCGTCACCATCCCCGAGGGCGAGTTCGTGACCATCTCGATCGGCGCCGCCGGCCGGGACCCGGACCGCTACCCCGACCCGGACCGCCTGGACATCACCCGCGCCCACTCCGGCTCGGTCGCCTTCGGCCATGGCATCCACCACTGCCTGGGCGCCCCGCTCGCCCGGCTGGAGGGCCGGATCGTCCTCAGCCGTCTGTTCGCGCGCCTTCCCGGGCTGCGGCTCGCCGCGGACCCGGACGAACTGAGCTGGCGCAGCAGCCTGATGATGCGCGGCCTCGAAGAACTCCCGGTGTTCACGGCGTGA	MARTDAPQAAPPADLFTPAFHQNPHEALAGLRRTAPAVPVMTPNGLRTWLVTGHEHARALLADPRLSKDMRVGRDLIPRNFVDPDKQREFLAESGERSQFPHVLSVHMLDSDPPDHTRLRRLVGRAFTARRVESLRPRITELTDELLDAMARHERLDLMEALAFPVPFTVICWLLGVPPDDRAAFRRWSNLLVSGAGTDEVREASASMITYLTELIEAKRNEPADDMLTDLVHARDAGDQLSSDELISMAFLLLVAGHETTVNLIGNGALALLTHPEVREQLAADESLWPGAVEEFLRYDGPVTNATWRFTTEPVEVGSVTIPEGEFVTISIGAAGRDPDRYPDPDRLDITRAHSGSVAFGHGIHHCLGAPLARLEGRIVLSRLFARLPGLRLAADPDELSWRSSLMMRGLEELPVFTA	MLRRLSLAAAVAAATGVAWAAQPTPLPTKTDLISVYKEAVDNNADLAAAQADYLARKEVVPQARAGLLPQLGAGARVGDTRIAFDERPATVKRNSQVVQATLSQPLFRADRWFQWQAAKETSDQARLEFSATQQDLILRSAETYFTVLRAQDNLATSKAEEAAFKRQLDQANERFDVGLSDKTDVLEAQASYDTARANRLIAEQRVDDAFQALVTLTNRDYSAIEGMRHTLPVVPPAPNDAKAWVDTAVQQNLRLLASNYAVNAAEETLRQRKAGHLPTLDAVAQYQKGDNDALGFANSAANPLVHYGKYVDERSIGLELNIPIYSGGLTSSQVRESYQRLNQSEQSREGQRRQVVQDTRNLHRAVNTDVEQVQARRQAIISNQSSLEATEIGYQVGTRNIVDVLNAQRQLYAAVRDYNNSRYDYILDTLRLKQAAGTLSPADLEALSAYLKQDYDPDKDFLPPDLAKAAAEQLQSKPRQQY	86.93	gnl|BL_ORD_ID|2005|hsp_num:0	2195			660	771	triclosan
BGC0000266.1|Rubromycin_27 # 25515 # 26396 # 1 # ID=1_27;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.727	BGC0000266.1|Rubromycin_27 	25515	26396	+	Loose	400	25.409	AAC(3)-IVa	31.43	3002539	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	GTGACCGCCGACCCCGCCCCGCCCCTACTGGAGGAGACACCCGTGGAACGTCAGGACACCGGACCCGCACCCCGCACCACCGAACGCCCCACCTGGGCCCCGCCCGAGGTCGACATCGACACCCCGAGCATCGCCCGGGTCTACGACCACTGGATCGGCGGCACCCACAACTTCCCGGCGGACCGGGAACTCGCCCGCAAGGTCGCGGCCGGCAACCCGGACCTCCCGGCCACCCTCAAGGCAAACCGCGCCTTCCTGCGCCGCGCGGTACGCGAGCTGTCCGCGCTCGGCATACGGCAGTTCCTCGACATCGGCTCCGGCATCCCGGCCGAGGGCAACGTGCACGACGTGGCCCTCGCCGCCCACCCGGACAGCAGGGTCGTTTACGTCGACATCGACCCGGTGGCCGTCGCGCACGGTCGGGCGCTGCTCGCCGACGAACCTCGGGCGGCCGTCTTCCAGGGCGACCTGTACAAGTCCCGGGAGATCCTGGAGGCGGAGGACACCCGTCGGCTGATCGACTTCGACCGGCCGGTCGCGCTGATCCTCGCCGCCGTACTGCACTTCGTCCCGGACGGCGACGATCCGCTCGCTCTGGTGCGCCGGTACACCGAGCGGCTGGCACCCGGCAGCGCCCTGGTGATCTCGCACGCCGGCGCGGAGGAGGTCCCGAGGACGGCGCCGGAGGCGGCCGAGCAGTACCGGGGCGCGGTGAGCCAGGTGATCTGGCGCGACAACCGGGAACTTGCCGCGCTGTTCGAGGACTTCGAGCTTGTGACGCCCGGTGTGGTCCGGGCCCCGCTGTGGCGCCCCGAACCGGCCGACACCCCCGACCCGGCGCTCGCGATGCTGGCCGGAGTGGCACTCAAACCGGCTCGGTGA	MTADPAPPLLEETPVERQDTGPAPRTTERPTWAPPEVDIDTPSIARVYDHWIGGTHNFPADRELARKVAAGNPDLPATLKANRAFLRRAVRELSALGIRQFLDIGSGIPAEGNVHDVALAAHPDSRVVYVDIDPVAVAHGRALLADEPRAAVFQGDLYKSREILEAEDTRRLIDFDRPVALILAAVLHFVPDGDDPLALVRRYTERLAPGSALVISHAGAEEVPRTAPEAAEQYRGAVSQVIWRDNRELAALFEDFELVTPGVVRAPLWRPEPADTPDPALAMLAGVALKPAR	MQYEWRKAELIGQLLNLGVTPGGVLLVHSSFRSVRPLEDGPLGLIEALRAALGPGGTLVMPSWSGLDDEPFDPATSPVTPDLGVVSDTFWRLPNVKRSAHPFAFAAAGPQAEQIISDPLPLPPHSPASPVARVHELDGQVLLLGVGHDANTTLHLAELMAKVPYGVPRHCTILQDGKLVRVDYLENDHCCERFALADRWLKEKSLQKEGPVGHAFARLIRSRDIVATALGQLGRDPLIFLHPPEAGCEECDAARQSIG	113.57	gnl|BL_ORD_ID|4915|hsp_num:0	639			69	273	dibekacin; sisomicin; apramycin; netilmicin; tobramycin; 6'-N-ethylnetilmicin; 2'-N-ethylnetilmicin; gentamicin
BGC0000266.1|Rubromycin_28 # 26403 # 27905 # 1 # ID=1_28;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.737	BGC0000266.1|Rubromycin_28 	26403	27905	+	Loose	500	40.0466	tet(C)	34.42	3000167	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGGACACGTCCCTCACCCCACAGGACTCCCCGCCGGCCACCGCGGGCTCCGCACCTCCGCGGGCCGGTGACCACAGGCCCGGCTTCGGCACACTGCTCGCGGTCGACCTGTGGGAGCGGTTCAGCTTCTTCGGCATGGCGGCGATCCTGGTCCTCTACCTGACCGCTTCCGAGGCGCGCGGCGGCATGGGCATGGCGCCGCAGCCGGCCACCGCGATCTTCGCGGCGTACATGTCGCTCTGCTTCATGGCCGGCCTGCCCGGCGGCTGGCTCGCCGACCGGGTGCTGGGTGCGCGCCGGGCCGTGCTGCTCGGCGGTGTGCTGATCACCTGCGGCCACGCGGTACTGGCGGTTCCGGTGACGGGCACGCTCTACGCCGGTCTGCTGCTGGTCGTCGGGGGGACGGGCCTGGTCAAGCCGGCCATGGCGGCGATGGTCGCGGGGGTCAGCGGGGACGGGGAGGGCCGCCGCGAGGCGGCCTTCTCGCTCTTCTACATGTGCATCCAGGTCAGCGCGCTCATCGCCCCCGTGGTCACCGGGCTGCTCGCCGAGCGCGTCGCCTGGCACCTCGGCTTCGCGGCGGCCGCCGTCGGCATGACGGCGGGACTGATCCAGTTCGCCCTGGGCCTGCGCCGGTACGGGGACGTCGGCGCGCGTCCGCCCCGCCCGGTGCCGCGCCCCGAGGCCCTCGCGATGCTCCGGCGCGCCGCGTGGGTCACGGGGTCGGTGGGCGCGCTGGTGGTGCTGCCGGTGTCCCGCGGACTGCTGCCTCTTCCCGTGGTGCTCGCCGCCCTCGGCCTGACGACCATCACCCTCCCGTTCTGGTACCTGAGGTCACTCCGCCTGGCCCACGCGCCGGGCACGGGCCACAGGCGCCGGCTGACCGGCTTCACCGCGCTGATGGCGGCGTCGGCCGCCTTCTGGATGATCTTCGCGCAGAGCGGTTCGGTGCTCAGCCTCTTCGCCGAGCGTCACACCGACCGGGATGTGCTCGGTTTCGAGGTCCCCGCGAGTTGGTTCCAGTCGGTGCACCCGCTCTTCGTCCTGCTGGTCGCCCCGCTCTTCGCCCGGCTCTGGGTACGGGCGCCGCGGGTGGACGTGCCGGTCAAGTTCGCGGGCGCGCTGATCGCGGCAGGCTCCAGCTTTCTGCTGATGGCGGTCGCGGCCACGCTCGCCGAGCACGGCCCGGTCGGCCCGCACTGGCTGCTGCTGGTCTACCTGCTGTACTCCTGCGGCGAGATCGCACTCGCCCCGGCGGGCCTGGCACTCGCCGCGGCGGTGGCCCCACCCGGCAGCACCAGCCGCCTGCTCGCGGTGAACGGCCTGTTCGGCGCGGTGGGAGTGGTCGTGGGAGGCCAGCTGTTCCGGCTGACGACGGTGCTGTCGCCGGCGACGTACTTCCTGCTGCTCGGCGCCTTCGTACTGGCAGTCGGCACAACCATCGCCCTCGGCACCCCGCGCCTACGCACACTCCTCGCCCTCCGGAGGAACCCCGGCCCCTGA	MDTSLTPQDSPPATAGSAPPRAGDHRPGFGTLLAVDLWERFSFFGMAAILVLYLTASEARGGMGMAPQPATAIFAAYMSLCFMAGLPGGWLADRVLGARRAVLLGGVLITCGHAVLAVPVTGTLYAGLLLVVGGTGLVKPAMAAMVAGVSGDGEGRREAAFSLFYMCIQVSALIAPVVTGLLAERVAWHLGFAAAAVGMTAGLIQFALGLRRYGDVGARPPRPVPRPEALAMLRRAAWVTGSVGALVVLPVSRGLLPLPVVLAALGLTTITLPFWYLRSLRLAHAPGTGHRRRLTGFTALMAASAAFWMIFAQSGSVLSLFAERHTDRDVLGFEVPASWFQSVHPLFVLLVAPLFARLWVRAPRVDVPVKFAGALIAAGSSFLLMAVAATLAEHGPVGPHWLLLVYLLYSCGEIALAPAGLALAAAVAPPGSTSRLLAVNGLFGAVGVVVGGQLFRLTTVLSPATYFLLLGAFVLAVGTTIALGTPRLRTLLALRRNPGP	MKSNNALIVILGTVTLDAVGIGLVMPVLPGLLRDIVHSDSIASHYGVLLALYALMQFLCAPVLGALSDRFGRRPVLLASLLGATIDYAIMATTPVLWILYAGRIVAGITGATGAVAGAYIADITDGEDRARHFGLMSACFGVGMVAGPVAGGLLGAISLHAPFLAAAVLNGLNLLLGCFLMQESHKGERRPMPLRAFNPVSSFRWARGMTIVAALMTVFFIMQLVGQVPAALWVIFGEDRFRWSATMIGLSLAVFGILHALAQAFVTGPATKRFGEKQAIIAGMAADALGYVLLAFATRGWMAFPIMILLASGGIGMPALQAMLSRQVDDDHQGQLQGSLAALTSLTSIIGPLIVTAIYAASASTWNGLAWIVGAALYLVCLPALRRGAWSRATST	126.26	gnl|BL_ORD_ID|892|hsp_num:0	900			141	582	tetracycline
BGC0000266.1|Rubromycin_29 # 28185 # 28691 # -1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=GGGGGG;rbs_spacer=3bp;gc_cont=0.655	BGC0000266.1|Rubromycin_29 	28185	28691	-	Loose	480	26.1794	OXA-372	40.74	3001558	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAAACCACGAAGCGCGGCCGCAACCGGCAGAGACTTCCCGTACACCTCAAGTACAACGTGCTATATCGAGGTCCACGGGGATGGGACCGTGACGCACGGGGACCAGCGCGCCGCCTACGAGCGCGCGGTCGCCGGAGAGTCCCGGCTGTTCGCCGTCTGGCCCGGCCAGTGGTCGAGCGACCTCTTCGAGATCGACGACCTGGACGAGTTCGCCAAGGCACTTGGGATCAAGCATGACGAAGAGCGAACGGGCCTGAAGGACCACATCCACAAGGTCGAATGGATCAAGGACCCGTACGGCAACGACAACCCTCGCAGCCAGTACCTCGACATCGACGTCACCCTCACCTGCGGCTGCTCCATCAACGACCGCCGTGCCTTCGCCGCGCAGATGAAGGAGCAGCAGGGCTGGGTCATCGCGACGAGCGGTGGCTGGTCGAAGAGCGGCAGGCCGGGCGGGCCGACGACCTACTCCCTGCGCGCGCGCCGCAAGAGCCTCACCTGA	MKPRSAAATGRDFPYTSSTTCYIEVHGDGTVTHGDQRAAYERAVAGESRLFAVWPGQWSSDLFEIDDLDEFAKALGIKHDEERTGLKDHIHKVEWIKDPYGNDNPRSQYLDIDVTLTCGCSINDRRAFAAQMKEQQGWVIATSGGWSKSGRPGGPTTYSLRARRKSLT	MMHIFLVFLILCSNFALAEDKAISAIFSTEGVDGTIILKSLRGDKTITHNDARASRRFASASTFKIFNTLIAVQENVVSLSGTAFRWDGKTHDIPDWNRDQTLESAFKVSCVWCYQEIAKQVGEETYRRYLTLARYGVLTNVADTTTFWLDGSFTVSAVEQIALLEKIYLRELPFRDEAYDALKQVMLAEQTDSYKLYAKTGWAARMNPQIGWYVGYVETSDDVWFFAINLTLRSELDLGLRQKITKAALRAERIIP	65.37	gnl|BL_ORD_ID|2168|hsp_num:0	3482			120	201	cloxacillin; oxacillin; cefalotin
BGC0000266.1|Rubromycin_30 # 29385 # 29561 # 1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.661	BGC0000266.1|Rubromycin_30 	29385	29561	+	Loose	1900	23.0978	mexQ	40.74	3003699	protein homolog model	n/a	n/a	macrolide antibiotic; carbapenem; tetracycline antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTACGTGATCACCGCGGTCCTCGCGGCGCTTGTCGCCGCTCTTGTCGGCAGCGTCGTGACCGTTGTCGAGGGAGGGCGTCCCACGGCGGCCTTCAAGACTGGAGCATTGACCTTCGCCGGCTCCTTGACGCTCCTTATGGTGGTCATGGGGGCCCTGGGGGTGGTGGGCTCGTGA	MYVITAVLAALVAALVGSVVTVVEGGRPTAAFKTGALTFAGSLTLLMVVMGALGVVGS	MTFPRFFIDRPIFAIVLSVLMMIGGIVSFFQLPLSEYPAVTPPTVQVTTAYPGANPDVIAQTVATPLEQAITGVEGMLYMSSQSATDGRMILTITFDQHIDPDMAQIQVQNRVSRVLSRLPDEVQRQGVVTQKTSPDILMVVHLLSPEQRYDPLYISNYAYLQVRDELLRLPGISDVVVWGAGEYSMRLWLDPDLIAARGLTAGEVIAAVREQNVQVAAGAVGQAPDSTAAFQVTVNTLGRLSDEEQFGDIIVRTGADGQVTRLRDVARIEMGGDAYALRSLLDGEPAVALQIIQSPGANALDTAEAVRATVARLEGNFPAGLSARIAYDPTVFVRASLQTVATTLLEAILLVVVVVVLFLRSWRASLIPLMAVPVSLVGTFAVMHLMGFSLNTLSLFGLVLSIGIVVDDAIVVVENVERHIENGEPPLQAARRAMDEVTGPIMAITSVLAAVFIPTAFLSGLQGEFYRQFALTIAISTILSALNSLTLSPALAGLLLRPRPAGGAVAGRFQRLLQVLGRPLRNAPEAYGNAVRKVVRVSGLALVVYGGLLGLTWVGFQAVPPGFVPMQDKYYLIGIAQLPNGASLERTDAVVRQMSRIGLDEPGVESVVAFPGLSVNGFVNVPNAAVMFFMLDPFESRTSADLGALAIAGRLQARFASIPDGFLGVFPPPPVPGLGTIGGFKMQVEDRGGAGLEALARQTQVLMMKATESGQLGGLMTSFDINAPQLEVVVDRTKVKSQGVRLADVFEALQVYLGSLYINDFNRFGRTYKVTAQADAPHRMQAEAIGRLQVRNAAGAMLPLSSFVTVTPSSGPDRVIHYNGYPSADISGGALPGVSSGQAVALMERLAGEVLPEGMTFEWTDLTYQQKLAGNSALFIFPLCVLLAYLILAAQYNSWLLPLAVLLIVPMCLLSAIAGVWLVGGDNNVFVQIGLVVLVGLAAKNAILIVEFARTLEAEGARALEAVVEACRLRLRPILMTSLAFIAGVVPLVMASGAGAEMRQAMGVAVFAGMLGVTLFGLFLTPVFYVLVRALAARLERRAGGSLAHLEGGRP	5.51	gnl|BL_ORD_ID|2010|hsp_num:0	2212			3078	3159	erythromycin; acriflavine; tetracycline; imipenem; trimethoprim; chloramphenicol; thiamphenicol; kitasamycin; rokitamycin
BGC0000266.1|Rubromycin_31 # 29558 # 31063 # 1 # ID=1_31;partial=00;start_type=GTG;rbs_motif=GGGGG;rbs_spacer=10bp;gc_cont=0.673	BGC0000266.1|Rubromycin_31 	29558	31063	+	Loose	475	25.7942	PST-2	26.53	3006977	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	PST beta-lactamase	GTGAGCGACATGAGTGCCCTTGGAGGACACGTGCAGGCCGGGAGTGCCTCCTCGCTCGACGAGGTTCTCGCGAAGGTGCGCCGACACCGCATGCATCTCTCGCGGCTGATGAACGCTCACGACGCGACCCGCCTCGTTCTAGGGTTGCTGTACCTGAGCAGGAAGGCGCACGCCGAGCCCGGCACCGGCGTACCGACATGGGCGTGGTTGATGGGGCAGCCGGCAGGGCGCGGCTCGGGAGTCCGCGCTGCCGTGAGCAAGTGTCTGAGCCACTGGCTTCCCGCAACCGACGAACAGGGTTCTGACGCGGGCACGAGGAGCCTGATGCCCGTTCCGCCCCCTGGTTCCGAAGGACACCTGCACGCTCTCGTCCAGGCCATCGGTTCCATCCAGCGGGTCGGGCCCCTGCTCGACCAGTGCCTCCGTGACCTCTCGGCGGACCAGGCTGAGGGCAGCCGCTACTTCACGCCGGATGACATGGCGCGTCTCATGGTTGGTGCGGCCGTCCCCCGTGACAGGCACAGAGTGCTGGACCCGGTCTGCGGTTCAGGAGGACTGCTCGTCGAGAGCCACCGCTACGTCCGCGAAAACGTCGGGCTGGACCCGACCATGTCTTTGCAGGGAAAGGAGCAGCACGCCCATACCTCACAGGTGGCCCGCATGAACTTCGCGGTACGTGGGATCACGGCTCACGTCTTCCCGCCCGGGGACAGCCTCGCGGATCCCGAACCGGAGCCCCACGACATCATCCTGGCCAACCTCCCCTTCAACCAGCGCGACTGGGCACCCGAGGACAAGACGGAGCGGGACGTCCGCCGGTCGCCTTCCCCGATCCCGGTCGATCCCAGGTGGCCGGAGGAGTCTCCGTCCAAAGGATCCGCCAACTCCGCGTGGATTCAGCACATCGCGCACGCGCTGGCTCCGGCCGGACGTGCCGTCTTCCTGATGGCCGACAGCGTGGCCAACAGCAGACAGCCCGTCACCCGAAGCGTTCGCGAGCGCCTCCTGCGTGACGATCTCGTCGAATGCGTGATCGCTCTGCCACCTCGCGTGTTCGGTCACTCCAAAGCCCCCGCCTGTCTGTGGGTGCTCAACAAGGACAAGAGCGCTCGCCCCGGCTGGGGTGCCCGGGACCGCCGTCGGCAGGTGCTGTTCATCAACGCGCGGCGAGCTTTCGAACCGGTCCCGAAGTCGAGAGCGCGGAGGCTGGGCGAGACGAACACGACAGCGGTCCTGGCCACCTTGGCGGCCTGGCGTGGCCTCTCCGAGAACGGTGCTGCGGCCTCGCCGTACGACGACGCCGTCGGCTGGTCCCGAAGCTGCTCCACCAGGGAGATCGCCGACCGCGAGTCCAGTCTGATGCCGACCTCGTACGTCATGGAGCCTCCTGGCCCAGAGCGGGACACACGGAGCCGGGTCGAGCAGCTCAAGCTCGAACTAACCGATCAGTTCCAGCAGATGCGCGCCCTGGAGCTCCAATTGCTGGACGCCTTGGAGGAGATGTGA	MSDMSALGGHVQAGSASSLDEVLAKVRRHRMHLSRLMNAHDATRLVLGLLYLSRKAHAEPGTGVPTWAWLMGQPAGRGSGVRAAVSKCLSHWLPATDEQGSDAGTRSLMPVPPPGSEGHLHALVQAIGSIQRVGPLLDQCLRDLSADQAEGSRYFTPDDMARLMVGAAVPRDRHRVLDPVCGSGGLLVESHRYVRENVGLDPTMSLQGKEQHAHTSQVARMNFAVRGITAHVFPPGDSLADPEPEPHDIILANLPFNQRDWAPEDKTERDVRRSPSPIPVDPRWPEESPSKGSANSAWIQHIAHALAPAGRAVFLMADSVANSRQPVTRSVRERLLRDDLVECVIALPPRVFGHSKAPACLWVLNKDKSARPGWGARDRRRQVLFINARRAFEPVPKSRARRLGETNTTAVLATLAAWRGLSENGAAASPYDDAVGWSRSCSTREIADRESSLMPTSYVMEPPGPERDTRSRVEQLKLELTDQFQQMRALELQLLDALEEM	MKLLFAALFVVMFCGLARAGDSLPELRIEKIAEGVYLHTSFQQVQGYGLVDANGLVVLDGQGAYIIDTPWSERDTAALVAWLQERNYQVKASVSTHFHDDRTAGIEYLNAISVPTYASARTNALLKQNGKALATETFDDAPLWLLEGKVEVFYPGAGHSVDNLVVWLPEQKLLNGGCFVRAAAAGTLGNTADAVVSEWAASAERLQRRYPDAQLVIPGHGVPGDVSLLEHTRKLAVAATAKD	207.02	gnl|BL_ORD_ID|4564|hsp_num:0	5634			186	333	
BGC0000266.1|Rubromycin_32 # 31063 # 32280 # 1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=7bp;gc_cont=0.661	BGC0000266.1|Rubromycin_32 	31063	32280	+	Loose	500	27.7202	Vibrio cholerae varG	34.88	3004289	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	Subclass B1 Vibrio cholerae varG beta-lactamase	ATGGAAGCCAATGCCGACCAGGCCTACTCGGGTAATGCGGCTTGGCAGACGACCTCCATCAACCATGAGCGGGTCCACGGGCGTATTTACACCACTTCCGGTTTCCTCGACGAAGCGGCTGCCGCTCAGACGGCAGGAGTCGTCAGCTCGACGTTCGTCCAGGGCGGCAGGATCCTCTCGCCCAGGGCCGATGAGTGCCGGCCCGGCGAATCCCCGCCTAGCCGGGCAATCCTCAGAGAGGGCGACCTGGCCGTCGTACTCGTCCGACGGGTGGGCGATTCCGCGCTGGTCACCGCCGAGCACGCGGGATGTACAGCGACCAGGTCGATCGGCATCATCCGCGCTGAACCGCACATAGTGCGGTGGCTGCGTATCTGGCTGCAGACACCGACGGCGAAGGCTCGTATCGACGAGGACGTGACGGCACATGTCGAGCCCACCATCAGCCTCGACACCCTCCACCGCATGCTGTTTCCACTGCCTCCGCCAGACGTCATCAACGCGTACCACCGAGCCTTCGGCCTCATCGACGAGATGACCGCCCTCTACCAGGAAACCGCCCGCAAGGCGGTGGAACTGGTCGACGCCCTCCATGACGACTGGGCGGCGACGATTCCGCCGTGGGAGGCACGGCCCCTCGCGAAAGTCGCCAAGTCGGAGACGGGCAAAGGTTCCGAACGCTCGATTCCCCCGTTGCCCACAGAACCCACCACCGACGTAACCGATGCAGTCGCCCCTAAAGATCTCTACGACCTCCCCGTGCCCCATGTCCAGAGGTTCCGTCTGAGCAGTCCGGCGAACGACGGCGAGGCACATCCTCCCGGCACCTTGATGCTGAGCACCCGCTCCGACGGTGCACACATCGCTGTGCCGAGCCGACCGGCAACACCACTCAGAGGCGTCGTGGCCGTACGACCTGCTGAGGACGAAGACGGTTGGTGGCTGCTCCACGAACTCAGGAGCAGGAGCAGCGACATCGCGCGGCTGGCGCAGGGCCAGAACGGGCGGGAAATCTCGGCCCGCGCCCTCAAGCGCCTGGAGGTCACCTGGCCGGACCGGTTCACGCGCACCGATTTCCACGCGATGGCCGATCCCCTGCACACCGCGGCGCGACTCCTGATCGCCAAGATCGCGACGCTGCACACCCTGCGGGACGCGCTCCTGCGCGACATCTCAGCGAAAGCCGGCGTCCTCCGGGAACCTGCAACGATGGCGTGA	MEANADQAYSGNAAWQTTSINHERVHGRIYTTSGFLDEAAAAQTAGVVSSTFVQGGRILSPRADECRPGESPPSRAILREGDLAVVLVRRVGDSALVTAEHAGCTATRSIGIIRAEPHIVRWLRIWLQTPTAKARIDEDVTAHVEPTISLDTLHRMLFPLPPPDVINAYHRAFGLIDEMTALYQETARKAVELVDALHDDWAATIPPWEARPLAKVAKSETGKGSERSIPPLPTEPTTDVTDAVAPKDLYDLPVPHVQRFRLSSPANDGEAHPPGTLMLSTRSDGAHIAVPSRPATPLRGVVAVRPAEDEDGWWLLHELRSRSSDIARLAQGQNGREISARALKRLEVTWPDRFTRTDFHAMADPLHTAARLLIAKIATLHTLRDALLRDISAKAGVLREPATMA	MFVSHLSFPHLIEERKMKLSTLALAPITAALLTFNASAKGHDHDNQRAIFFPGETVQDTVKVEVEPSATQSLKLGQKINNLYERQFDNSQATVQKLGKNTYWIGVNYYNATVVVNEDSVLLIDPLGDGRIDALFKGVQSITNKPITTIMYSHYHLDHLGGGNQLVDLIKKNYPKVDKIRVIASQTVADKINQHAEVGENGVKTPKVPAPNDIYDLTKPQTVQFGSMKIKMMAPKGSGHTPDNTMILIPSDRVLHFADMINPDQLPFYNFAGAEHFHGYEEDLQSLLSKPLSKQWDFINGGHGNIGSKQDVKDLLEYIADIRTEVGKQLEVAPYTPVLSDGNHFVWFKRWQDEITNNVHTALANKYGHMYGFDSGVVETHAAMILADMIDH	103.85	gnl|BL_ORD_ID|2428|hsp_num:0	2842			621	750	meropenem
BGC0000266.1|Rubromycin_19 # 18749 # 20035 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.730	BGC0000266.1|Rubromycin_19 	18749	20035	+	Loose	750	198.749	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	34.9	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGACAGCCGGACACCGACGCGCGGTGATCACCGGGGTGGGGGCCGTCGCGCCCGGCGGGATCGGGCGGGACGCCTACTGGGACCTGCTCACCGCCGGACGCACCGCCACCCGCCGCATCAGCCTGTTCGACCCGGCCGGCTTCCGCTCCCAGGTCGCCGCCGAGTGCGACTTCGATCCGCTCGCCGCGGGGCTCACCCCCCAGGAGGCCCGCCGGATGGACCGGGCCGGTCAGTTCGCGGTCGTCGCCGCCCGTGAGGCCGTCGCGGACAGCGGAGTCGAGCTGCCCGGCACCGACCCGGAGCGGGTCGGCATCAGCATCGGCAGCGCCGTCGGCTGCACCATGGGCCTGGAGGAGGAGTACGCGGTCCTCTCCGACGGCGGACGCGACTGGCTGGTCGACCACAGCTACGGCGTCCCCCACCTCTACGGCTACATGGTGCCCAGCACCCTCGCCGTCGAGGTGGCCCGCCAGGCGGGAGCCGAGGGGCCGGTCGCGCTGATCTCCACCGGCTGCACCTCGGGACTGGACGCCATCGGACACGGCGTCCAGCTGATCGAGGAGGGCAGCGCCGACATCGTGCTCGCCGGCGCCACCGACGCCCCGCTGTCGCCGATCACCTCCGCCTGCTTCGACGCCATCAAGGCCACCACCGCCAACAACGACGATCCCGAACACGCCTCCCGGCCCTTCGACGGGCAGCGCGACGGCTTCGTCCTGGGCGAGGGCTCCGCCGTCATGGTGATAGAGGAGCTGGAGTCGGCCAGACGCCGCGGCGCCACCGTGTACGCCGAGATCCTCGGTTTCGCGGGCCGCAGCAACGCCTTCCACATGACCGGACTCAAGCCCGACGGCCGGGAGATGGCGGAGGCCGTCCGGGTCGCCCTGCACCGGGCGCGGCTCGACCCGGGCGCCATCGACTACATCAACGCCCACGGCTCGGGCACGAAGCAGAACGACCGGCACGAGACCGCCGCGTTCAAGCGCAGCCTGGGACAGCGGGCCCACGAGGTGCCGGTCAGCTCCATCAAGTCGATGATCGGGCACTCGCTCGGCGCCATCGGCTCCCTGGAGATCGCCGCCTGCGCTCTCGCCCTGCGCCACCAGGTCGTCCCGCCGACGGCCAACCTGTCCACGCCCGACCCCGAGTGCGACCTCGACTACGTGCCGGTGACGGCCCGCGAGCACCGTATGGACCGGGTGCTCAGCGTCGGCAGCGGCTTCGGCGGCTTCCAGACGGCGATGGTCCTGGGCCGGCCCCACCTCGCGCACGGGGAGGCGGCATGA	MTAGHRRAVITGVGAVAPGGIGRDAYWDLLTAGRTATRRISLFDPAGFRSQVAAECDFDPLAAGLTPQEARRMDRAGQFAVVAAREAVADSGVELPGTDPERVGISIGSAVGCTMGLEEEYAVLSDGGRDWLVDHSYGVPHLYGYMVPSTLAVEVARQAGAEGPVALISTGCTSGLDAIGHGVQLIEEGSADIVLAGATDAPLSPITSACFDAIKATTANNDDPEHASRPFDGQRDGFVLGEGSAVMVIEELESARRRGATVYAEILGFAGRSNAFHMTGLKPDGREMAEAVRVALHRARLDPGAIDYINAHGSGTKQNDRHETAAFKRSLGQRAHEVPVSSIKSMIGHSLGAIGSLEIAACALALRHQVVPPTANLSTPDPECDLDYVPVTAREHRMDRVLSVGSGFGGFQTAMVLGRPHLAHGEAA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	102.88	gnl|BL_ORD_ID|1968|hsp_num:0	1943			195	1245	isoniazid
